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Purpose: The International Commission of Radiological Protection (ICRP) advises 
that in principle Diagnostic Reference Levels (DRL) could be used in fluoroscopically 
guided interventional procedures to avoid unnecessary stochastic radiation risk. The 
increase in complexity of interventional procedures, combined with a lack of 
specialist training on radiation techniques, poses a significant risk to patients. These 
risks have not gone unnoticed by government authorities worldwide and in 2015 the 
South African Department of Health: Directorate Radiation Control issued 
requirements to license holders of interventional fluoroscopy units, requiring that a 
medical physicist optimize their radiation usage using DRLs. The Dose Area Product 
(DAP) quantity measured for each patient represents a dosimetry index, the value of 
which for the purpose of improvement should be optimized against the DRL. In this 
dissertation, I aim to establish if DRLs in the South African private healthcare 
interventional theatres are high compared to international levels and whether DRLs 
will optimize the doses used. 
Materials and methods: Standard interventional procedures performed in 27 private 
hospitals’ vascular, cardiac and electrophysiology interventional theatres were 
identified and included in this dataset. Each entry in the database includes a 
procedure description, the Dose Area Product (DAP) and the screening time. The 
3rd quartile of the distribution was used to calculate DRLs. The mean international 
DRLs for the different cases were calculated and compared with local levels. A Log10 
t-test was used to evaluate if dose was optimized or not. 
Results: Dose and exposure data was recorded in 6 quarters which included 20415 
procedures performed from July 2012 to December 2013. This included 3911 data 
iii 
 
points for Coronary Angiograms (CA), 7547 Coronary Angiograms & Left 
Ventriculography (CA+LV), 1885 CA + Percutaneous Trans-luminal Coronary 
Angioplasty (PTCA) + 1 Stent, 1175 Permanent Pacemakers (PPM), 280 
biventricular PPM and 675 radiofrequency ablation cases. DRLs were calculated for 
the above procedures with high case numbers. The 2012 DAP values were used as 
a baseline for this study and the DAP values recorded at the end of 2013 as current 
results. Standard deviation, 1st & 3rd quartiles and inter-quartile ranges were 
calculated. DRLs determined for procedures includes: CA (57.0 Gy.cm2), CA+LV 
(63.5 Gy.cm2), CA + PTCA + 1 Stent (176 Gy.cm2), PPM (36.2 Gy.cm2), biventricular 
PPM (117 Gy.cm2) and radiofrequency ablation (65.7 Gy.cm2).  
Conclusion:  The DRL for these six procedures improved between 9 - 45 % and the 
t-test results confirmed this hypothesis for all procedures except biventricular PPM. 
We attribute the improvement seen to various factors, including increased 
awareness, changes in imaging techniques, new and upgraded imaging equipment 
and the improvement of incident management. The mean of international levels 
published was higher than the DRLs calculated in this work. This means South 
African private sector interventional doses are not high compared to international 
levels. Based on the number of cases recorded and the national spread of the 
participating private hospitals, I propose that these DRLs calculated could be 
considered as national guidance to interventionists attempting to optimize their 
techniques through DRLs in South Africa. 
Keywords: Diagnostic Reference Level (DRL), Dose Area Product (DAP), 
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CHAPTER 1 INTRODUCTION 
1.1 Introduction 
Are radiation doses used in South African private healthcare interventional 
laboratories high compared to those published internationally and will establishing 
dose reference levels optimize the doses used?  
Radiation is widely used in medicine for diagnostic, interventional or functional 
imaging and for radiotherapy. Since the discovery of the Roentgen ray late in the 19th 
century the use of radiation has helped clinicians to diagnose and treat a vast array 
of conditions and malignancies.  The benefit of these modalities is unequalled in 
modern hospitals and has led to x-ray imaging being utilised throughout the entire 
hospital and it is no longer confined to the radiology department.  
Today’s X-ray imaging equipment mostly utilizes digital technology which has 
obvious advantages because of the wide dynamic range and ease of use. Many 
specialist doctors in various disciplines are using and relying on x-ray imaging to 
perform surgeries and clinical procedures on patients. Unfortunately digital x-ray 
technologies can lead to overexposure of patients.(1)  
Interventional cardiology, being less invasive than surgery, offers great benefit to 
patients. These specialists, specifically in cardiology and those doing vascular 
procedures, perform complex surgeries under fluoroscopic guidance which can 
cause high peak radiation doses to the patient’s organs. (2, 3) 
Patients that receive interventional cardiology or vascular procedures have a better 
prognosis, because the interventional techniques are less invasive than traditional 
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surgery, which in turn lowers the chance of infection.  Another benefit to 
interventional surgery is that the patient recovers quicker than they would after 
traditional surgery, which leads to shorter hospitalisation and lower costs associated 
with procedures. (4) For some patients interventional cardiology is the only option, 
because of age, pathology or co-morbidities and because they may likely not survive 
invasive surgical intervention.  (5, 6) 
Ionizing radiation imaging carries with it a risk to the patient and has the potential to 
cause stochastic and deterministic adverse radiation effects. (2, 7) Deterministic 
tissue effects materialize when threshold doses are exceeded and some examples 
thereof are erythema, dermal atrophy and necrosis. (8)  
X-ray units in interventional radiology typically have an energy range of between 40 
kV – 150 kV. At this X-ray energy skin reactions are the most prevalent deterministic 
effect, because this is the organ that receives the most radiation dose during a 
fluoroscopic procedure.  In megavoltage radiotherapy where higher energy photons 
deposit their peak dose to deeper tissue, skin sparing is possible. Even so, skin 
reactions are common in radiotherapy treatments because of the high dose ranges 
required to treat tumours. (9)  
Management of these reactions is possible to lessen the extent of injury during the 
course of treatment. (10, 11) Interventional procedures done using fluoroscopy 
guidance do not commonly exceed deterministic threshold doses for routine 
procedures, but it is possible for long complex cases or when poor radiographic 
technique is used. (2, 3, 12, 13)  
The classification of stochastic effects or random radiation effects has no threshold 
dose and some examples are radiation induced malignancies or cancer, infertility 
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and birth defects.   Stochastic effects are not as easily measurable as deterministic 
effects, because there is no threshold dose indicating possible effect and no 
assurance, especially at low doses, that an effect is related to the exposure received. 
(7, 14)  
Interventional cardiologists have a high usage of interventional x-ray machines, but 
unfortunately their training does not include as much radiation physics or radiation 
safety as that of radiologists. (15)  One result of the lack of training may be that 
interventionists are unaware of the amount of radiation dose to the skin, even today 
on modern technology.(3) Interventional procedures are becoming increasingly more 
complex in many specialities, as the types and uses of catheters become more 
advanced.(5, 16)   
The dangers related to diagnostic imaging and specifically the deterministic skin 
reactions possible during extended fluoroscopically guided procedures has not gone 
unnoticed by governments and authorities responsible for the safe use of these 
modalities.  
In South Africa, since 2007, it has been regulated that Dose Area Product (DAP) 
meters be incorporated in fixed fluoroscopy units installed and that the DAP readings 
be recorded for each patient. This is specified in the electronic product licensing 
requirements issued by South African Department of Health, Directorate Radiation 
Control (DoH DRC).(17)  
In 2012 DoH DRC imposed further changes to regulations, mandating the license 
holder to ensure that radiation doses are optimized during clinical procedures. In 
2015 additional requirements were issued to license holders of interventional 
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fluoroscopy units, requiring the use of an medical physicist to optimize their radiation 
usage using DRLs.(17) 
The increase in complexity of interventional procedures combined with a lack of 
specialist training on radiation techniques poses a significant risk to patients. 
Currently, in the South African environment, there are limited publications referring to 
DRLs with no full publications addressing interventional cardiology. These factors set 
the stage for this study and emphasize its need.  
In this study, I aim to establish if DRLs in the South African private healthcare 
interventional theatres are high compared to international levels and whether DRLs 
will optimize the doses used. Additionally I am confident to propose national DRLs 
for common interventional procedures specific to the South African population in the 
private healthcare sector.  
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CHAPTER 2 LITERATURE REVIEW 
2.1 Biological Effects of X-rays 
 
The history of radiation and the discovery of X-rays in 1895 by Wilhelm Roentgen 
have been inundated by publications describing the biological risks because of its 
use. (3, 14, 15, 18, 19)  In the early years of radiation use in medicine there were 
various and conflicting theories attempting to explain the physical or be it chemical 
response and resulting damage to tissue. (20-22)  
Ionising radiation produced by interventional radiology has the ability to penetrate 
tissue and deposit energy in cells. (23) This deposition of energy causes, on a 
cellular level, biological effects within the structural components of cells. These 
biological effects can be damaging to cells and can lead to different types of cellular 
response due to the radiation dose received. (2, 3, 24)  
The type of radiation and the dose thereof impacts the cellular response. (25) A 
further danger of radiation is that the damage caused by X-rays does not stimulate 
the human sensory system nor does it cause noticeable heat sensation to the patient 
being imaged. (3)  
Radiation effects are broadly classified into deterministic and stochastic effects. The 
ICRP 103 defines a deterministic effect as “An injury in populations of cells, 
characterised by a threshold dose and an increase in the severity of the reaction as 
the dose is increased further. Also termed tissue reaction. ” (26) As noted in this 
definition deterministic tissue effects materialize when threshold doses are exceeded 
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and, importantly, the severity of these effects are related to the amount of dose 
received.(8)  
Wagner et al. (23) discuss various potential biological effects resulting from radiation 
dose during interventional procedures, but the most prevalent effect is that of the 
skin.  Listed in Table 2.1.1 are some examples of likely skin reactions, which include 
erythema, dermal atrophy and even dermal tissue necrosis.  
X-ray units in interventional radiology typically have an energy range of between 40 
kV – 150 kV. At this x-ray energy skin reactions are the most prevalent deterministic 
effect, because it is the organ that receives the most radiation dose during a 
fluoroscopic procedure.   
Salvo et al. (27) states that approximately 85% of patients treated with radiation 
therapy will experience a moderate-to-severe skin reaction. These skin reactions 
often include itching, pain, delays in treatment, discoloration of appearance. 
Subsequently most deterministic skin reactions lead to a decrease in quality of life.  
Management of deterministic reactions is possible and this can lessen the extent of 
injury during the course of treatment. (10, 11, 28)  
Unlike in megavoltage radiotherapy, interventional procedures done using 
fluoroscopy guidance do not commonly or routinely exceed deterministic threshold 
doses. Yet it is possible for long complex cases or when poor radiographic technique 
is used. (2, 3, 12, 13, 29)  
As per the ICRP definition of a deterministic effect, the severity is directly related to 
the skin dose received. Table 2.1.1 displays the possible type of effect relevant at 
different peak dose levels to the skin. The first sign of effect is noted by Wager et al., 
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(3) as being transient erythema of the superficial dermal layers at a dose of 2 Gy. 
This level may be seen as being the threshold dose as described in the ICRP 
definition of a deterministic effect. (26)  
Other authors have proposed different skin threshold dose levels that could lead to a 
reaction; Wells et al. (10) describe the threshold dose as 1.5 Gy. Neofotistou et al. 
(30) proposed a DAP skin reaction investigation level of 300 Gy.cm2 for 
interventional cardiology procedures as this could likely cause a skin reaction. 
On the end of the spectrum of deterministic skin reactions, Table 2.1.1, shows very 
severe reactions occurring at doses exceeding 7 - 10 Gy.  Various authors have 
published literature surveys and their experiences with skin reactions in fluoroscopy, 
some occurring because of repeated procedures and other because of poor 
radiographic techniques.  (2, 3, 31) 
Table 2.1.1 indicates the time until the effect would appear, noted as the onset of the 
reaction. This is very relevant to the possible treatment or monitoring of such an 
occurrence. Koenig et al. (2, 3) list time periods of hours for early transient erythema 
up to one year for late dermal necrosis and second phase dermal atrophy.  
In interventional fluoroscopy, being a less invasive technique, patients generally are 
fit to be discharged from hospital soon following their procedures. This could lead to 
radiation induced effects going unnoticed and brings with it the risk of 
mismanagement of the injury, should a general practitioner or dermatologist not 




Table 2.1.1: Threshold skin entrance doses for various skin injuries. Table 
reproduced from Wager et al. (3)  
Effect Dose (Gy) Onset 
Early transient erythema 2 Hours 
Main erythema 6 ~10 days 
Temporary epilation 3 ~3 weeks 
Permanent epilation 7 ~3 weeks 
Dry desquamation 14 ~4 weeks 
Moist desquamation 18 ~4 weeks 
Secondary ulceration 24 ~6 weeks 
Late erythema 15 ~8-10 weeks 
Ischemic dermal necrosis 18 >10 weeks 
Dermal atrophy (1st phase) 10 >12 weeks 
Dermal atrophy (2nd phase) 10 >1 years 
Induration (invasive fibrosis) 10 * 
Telangiectasia 





Skin cancer * >5 years 
* no value indicated in original table.(3) 
 
The ICRP defines stochastic effects of radiation as, “Malignant disease and heritable 
effects for which the probability of an effect occurring, but not its severity, is regarded 
as a function of dose without threshold.”  (26)  As noted in this definition stochastic 
effects, or random radiation effects, have no threshold dose, which means even at 
very low doses there is a possible risk of a radiation detriment.  
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The definition notes that the probability of an effect, and not its severity, can be 
regarded as a function of dose. This alludes to a problem that various authors have 
explained, being the difficulty to relate the stochastic radiation effect to a delivered 
dose or procedure. Some examples of stochastic radiation effects are radiation 
induced malignancies like cancer, or infertility and birth defects. (14, 32, 33)  
Predicting the incidence of stochastic effects and relating that to dose has mostly 
been done using information for accidents or incidents where large populations were 
exposed to high levels of radiation.  Dose levels and cancer incidence were 
evaluated for atomic bomb survivors of Hiroshima and Nagasaki (34, 35), as well as 
for nuclear accident survivors of Chernobyl. (36, 37)  
In the clinical environment, stochastic effects are not as easily measurable as 
deterministic effects. This is because there is no threshold dose flagging a possible 
effect and no assurance, especially at low doses, that an effect is related to the 
exposure received. (7, 14)   
Various authors have attempted to estimate the cancer risk for populations receiving 
medical procedures, specifically Computed Tomography (CT) and CT angiography.  
These authors report large variations and uncertainties in the resultant population 
risk profile, but concur that increased risk is associated with increased dose. They 
encourage medical professionals to stringently justify radiation usage and to optimize 
the dose used to essential levels. Because of the late onset of stochastic effects, 
emphasize is placed on the protection of woman of reproductive capacity and 
children.  (38-40) 
In Table 2.1.1., Wagner et al. (3), indicates skin cancer as being a possible effect 
after a time period of five years following exposure. They do not offer a dose level 
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where this effect would be present, which concurs with the definition of a stochastic 
effect that may be induced at any dose. The severity is independent of dose, 
although the probability of occurrence increases as dose increases.  
This delayed reaction and uncertainty has led to some clinicians trying to mitigate 
this risk by monitoring patients. Knautz et al. (41) advocate regular follow-up to 
detect possible malignancies in patients with high radiation doses received during 
Transjugular Intrahepatic Protosystemic Shunt (TIPS) placement. This premise could 
be expanded to radiotherapy, long interventional procedures and other modalities 
using high radiation doses.  
Both types of possible reactions to radiation discussed in this section are serious and 
the consequences of irresponsible use of radiation could be dire for patients. (29) 
 
2.2 Justification and Optimization of Dose  
 
Considering these risks involved in the use of radiation, the principle of justification of 
use becomes very important. Justification of a procedure involving radiation 
incorporates not only radiation risk, but many other factors. (42, 43)  
The council directive of the European Union explains the principle of justification 
when using medical radiation as, “Medical exposure shall show a sufficient net 
benefit, weighing the total potential diagnostic or therapeutic benefits it produces, 
including the direct health benefits to an individual and the benefits to society, 
against the individual detriment that the exposure might cause, taking into account 
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the efficiency, benefits and risks of available alternative techniques having the same 
objective, but involving no or less exposure to ionising radiation.” (43) 
A well-known term in radiation protection in radiology is “As Low As Reasonably 
Achievable” (ALARA), which describes the process of safety and optimization for the 
responsible use of radiation. The ALARA principle goes hand in hand with the 
concept of justification described by the European council directive. (43)  
When radiation is used in medicine, the benefit of the modality needs to be weighed 
against the possible radiation risk. The ICRP promotes this principle in the 
management of the safe use of radiation in medicine. (26, 44)  The ICRP 105 
describes three levels of justification in radiological practice: 
 
1. The first level is a statement that, “the proper use of radiation in medicine is 
accepted as doing more good than harm to society.” This is accepted by the 
ICRP and not discussed further. (44) 
 
2. The second level of justification is that, “a specified procedure with a specified 
objective is defined and justified.” In the discussion of the second justification 
level, they emphasize that there must be relevant symptoms or population risk 
indicators present to justify a procedure. The justification must also consider if 
the likely condition can be diagnosed and treated. They describe the aim of 
the second level of justification as, “to judge whether the radiological 
procedure will improve the diagnosis or treatment, or will provide necessary 




3. The third level of justification is that, “the application of the procedure to an 
individual patient should be justified.” The emphasize being that justification 
must be to achieve specific objectives considering the characteristics of the 
individual involved. It is also noted that the justification process should be 
done before the procedure. (44)   
 
When comparing the NRCP report no 93 (45) of 1986 to the NCRP report no 160 
(46) of 2006, it is evident that radiological exposures have increased substantially 
within this period. The NRCP report 160 describes that doses resulting from medical 
exposures exceed background dose levels for the population of the United States of 
America.  (47) 
Figure 2.2.1, reproduced from the NRCP report 160 (46), shows the breakdown of 
the radiation dose contribution from different radiology techniques. Computed 
tomography is the largest contributor, nuclear medicine is the second largest and 
interventional fluoroscopy third largest. Conventional radiology has the highest 
incidence of procedures performed, but contributes to the least dose because of 
lower exposure levels per exam.  
The report adds that interventional procedures are fewer in occurrence, but the dose 
per incidence is higher, which leads to the third highest contributor to population 
dose. (46) This indicates clearly how lower dose techniques could lead to lower 






Figure 2.2.1: Distribution of the radiation dose (S) resulting from different types of 
medical exposures for the patient population in the United States of America in 2006. 
Graph reproduced from the NRCP report 160. (46) 
 
Figure 2.2.2 shows the distribution of all interventional procedures performed in the 
USA as part of the NRCP 2006 report. (46)  Non-vascular interventional fluoroscopy 
procedures accounted for 52% of cases performed and cardiology procedures 
accounted for 28%.  Non-cardiac arteriography and vascular procedures were 
responsible for the remaining cases.  
Adding to the increased usage of medical imaging as reported in the NRCP report 
160 (46), interventional fluoroscopy procedures are becoming increasingly more 
complex in many specialities. The types and uses of catheters are becoming more 
advanced, which has led to doctors attempting difficult and long procedures using 




Figure 2.2.2: Distribution of the number of interventional fluoroscopy procedures 
recorded for the population in the United States of America. Graph reproduced from 
the NRCP report 160. (46)  
 
Until recently, heart valve placement was done though surgical Aortic Valve 
Placement (AVR), which involves opening a patient’s chest cavity to give the 
surgeon access to the heart valves. Today, in many interventional cardiac theatres, 
there is an alternative procedure: the Transcatheter Aortic Valve Implantation (TAVI), 
which is done using special catheters.(49)  
This is one example of cardiology, but this notion is seen in many other specialist 
fields. In neurology, one treatment of an Arteriovenus Malformation (AVM) is to place 
a combination of glue and coils in the affected aneurysm to minimize the risk of 
rupture. (50) Another example where high doses are often recorded in vascular units 
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is when complex Endovascular Aneurysm Repair (EVAR) procedures are done. (51, 
52) 
The increase in difficulty of interventional procedures, specifically for cardiology, 
leads to longer procedure times and increased radiation dose usage. Figure 2.2.3 
shows the dose contribution to the USA population from the different procedure 
types. (46)  
Cardiology, although only accounting for 28% of all interventional procedures, 
contributed the highest population dose in this segment. Cardiac procedures 
contributed 52% of the population dose resulting from all interventional fluoroscopy 
uses. This shows that the procedures done in cardiology are of significance for dose 
reduction or when technique optimization and justification are considered. 
As seen in Figures 2.2.2-3, cardiology and specifically the interventional cardiologist 
have a high usage of interventional x-ray machines and the population dose 
contribution from these procedures is significant.  Vlietstra et al. (15) noted that 
cardiologist training does not include much radiation physics or radiation safety 
training, in contrast to the training received by radiologists. One result of the lack of 
training may be that specialist doctors using interventional fluoroscopy are unaware 
of the amount of radiation dose to the skin, even on modern technology. (3)   
Considering the risks involved of stochastic and deterministic nature, this lack of 
training and awareness is unfortunate and could be harmful to patients receiving 





Figure 2.2.3: Distribution of the population dose from the same interventional 
fluoroscopy procedures recorded in the United States of America. Graph reproduced 










2.3 Diagnostic Reference Levels 
 
It is reasonable for a patient to assume, when being x-rayed, that standard 
diagnostic radiology procedures from one population should have similar, or at least 
comparable, radiation doses. (53) Historic surveys of patient doses have shown that 
this assumption is incorrect.  
Detailed surveys of patient doses as early as the 1950’s in the United States and 
the1980’s in Europe indicate a wide variation in clinical doses needed to perform x-
ray examinations. Reports of a variation in doses of as high as twenty fold were 
described in these initial surveys. (53, 54)  
Shrimpton et al. (54), concerned by the wide variation in doses seen in the British 
surveys from the 1980’s, published work suggesting guidance doses for medical x-
ray examinations in Britain. They suggested that by making simple measurements 
on samples of patients to obtain dose levels, individual x-ray departments could 
evaluate their own mean doses compared to these levels. He proposed that if an 
observation showed that a department significantly exceeds these levels, the 
radiographic practice should be adjusted or optimized. This could lead to the 
lowering of doses used at radiographic practises. (54) 
The ICRP first introduced the term Diagnostic Reference Level (DRL) in their report 
60 (55) and soon followed with detail in report 73 of 1996. (56, 57) This report was 
later followed by supplementary reports 103, 105 and additional guidance on DRLs. 
(26, 44, 58) 
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The European Union Council Directive published in 1997 defines diagnostic 
reference levels as, “dose levels in medical radio diagnostic practices or, in the case 
of radio-pharmaceuticals, levels of activity, for typical examinations for groups of 
standard-sized patients or standard phantoms for broadly defined types of 
equipment. These levels are expected not to be exceeded for standard procedures 
when good and normal practice regarding diagnostic and technical performance is 
applied.” (43)  
Today the term diagnostic reference level is used widely in medical imaging and the 
ICRP report 103 published in 2007 has refined this definition as,  “Diagnostic 
reference level used in medical imaging with ionising radiation to indicate whether, in 
routine conditions, the patient dose or administered activity (amount of radioactive 
material) from a specified procedure is unusually high or low for that procedure.” (26) 
Currently, in the international context, the use of DRLs to optimize radiography 
procedures is not a new concept and various authors and institutions have published 
DRL data for radiography and even dental radiography. (5, 12, 59-61) There are 
numerous attempts to establish DRL’s for interventional radiology, but one constraint 
appears to be the restricted amount of procedure types and procedure combinations 
incorporated in these studies. (62, 63) Interventional DRL’s are available 
internationally for procedures like, e.g. Coronary, Cerebral and Renal Angiography, 
Left Ventriculography (LV) and Pacemaker Implantations.(64)  
The concept of using a DRL in interventional radiology, which includes interventional 
cardiology, is more complex than for general radiology. The ICRP report 105, and 
ICRP’s additional advice on DRLs, recommends that in principle DRLs could be 
used in fluoroscopically guided diagnostic and interventional procedures to avoid 
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unnecessary stochastic radiation risk. This is cautiously said as the ICRP observed 
that the distribution of doses in interventional radiology is very wide, which may be 
attributed to the complexity of individual clinical cases. (44, 58)  
DRLs form an integral part of dose optimization and if correctly applied can lead to 
lower population doses. (12, 54, 65) For dose optimization and for the purpose of 
evaluation the Dose Area Product (DAP) quantity measured for each patient 
represents a dosimetry index, the value of which should be optimized against the 
DRL, this varies for each procedure and can be used as a tool to comply with the 
ALARA principle.(66)  
The European Commission provides council directives and guidance to their 
member states. In their guidance of 1999 (65), the definition of the DRL has not 
changed since the 1997 council directive (43), but specific guidance is added for the 
establishment and use of diagnostic reference levels. The 1999 guidance noted the 
use of the 3rd quartile of the distribution to set guidance levels.  
This is motivated as being an appropriate method because the DRL distribution 
curve (histogram) is known as usually being skewed with a long tail representing 
cases with high doses.  Considering the aim of DRLs for optimization, they 
emphasize that the DRL should be higher than the mean or median of the cases, 
because this is the level which, if consistently exceeded, should trigger corrective 
actions. (65)   
The 3rd quartile method is also noted widely by authors investigating reference level 
and appears to be the most popular way for determining and comparing DRLs. (5, 
63, 64, 67) 
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In Italy, Padovani et al. (68) introduced diagnostic reference levels in 1998 following 
the European union council directive (43) of the preceding year. They used five 
cardiology centres in Italy and investigated their most common procedures. They 
found that for the population of Italy, reference values of 70 Gy.cm2 for the combined 
procedure of coronary angiography and left ventriculography and 120 Gy.cm2 for 
angioplasty were reasonable recommendations.  
In 2004 Aroua et al. (69) suggested temporary reference levels in diagnostic and 
interventional radiology in Switzerland. They used average doses and estimated 3rd 
quartiles from a survey of 257 different types of examinations. Their method of 3rd 
quartile estimations was to multiply mean results with a factor of 1.5 to compare 
them with 3rd quartile DRLs published internationally.  
In 2011 Samara et al. (67) emphasized the large variation seen in patient exposures 
in interventional cardiology in Switzerland.  They proposed a multicentre 3rd quartile 
DRL of 102 and 125 Gy.cm2 for Coronary Angiography (CA) and Percutaneous 
Coronary Interventions (PCI) respectively.  
In 2003 Neofotistou et al. (30) published preliminary reference levels in interventional 
cardiology for Europe. They proposed reference levels of 57 and 94 Gy.cm2 for CA 
and PCI respectively. Interestingly, they also included in their reference level 
guidance the amount of fluorography frames and also exposure times. For the two 
procedures a time of 7.5 minutes and 17 minutes and frame counts of 1250 and 
1300 were suggested for CA and PTCA respectively.  
In the same vein of work as that of Neofotistou et al. (30), Padovani et al. (63) set 
reference levels for European cardiac interventional procedures in 2008. They used 
patient information collected in nine European partner countries and evaluated close 
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to 2000 procedures. They divided cardiac cases in three groups, namely CA, PTCA 
and a combined group of electrophysiology procedures which included 
radiofrequency ablation and pacemakers. The DRLs were expressed as rounded 3rd 
quartile values and similar to Neofotistou et al. (30) included time and frames used.  
The Padovani et al. (63) DRLs were calculated as 45, 85 and 35 Gy.cm2 for CA, 
PTCA and the combined electrophysiology procedures respectively. The time was 
6.5, 15.5 and 21 minutes for the 3 groups of procedures. The frames were only given 
for CA and PTCA as 700 and 1000.  This showed a reduction from the Neofotistou et 
al. (30) proposal done five years earlier. They attribute this reduction in the DRLs as 
being a direct result of the reduced number of frames used on average for these 
procedures. This shows that a DRL establishment can lead to a dose reduction in 
populations.   
In 2012 Miller et al. (64) proposed initial interventional cardiology reference levels for 
the United States. They used data from 171 facilities in 30 states in the United 
States, collected by centres participating in their Nationwide Evaluation of X-ray 
Trends (NEXT) survey. The procedures selected in this study included diagnostic 
cardiac catheterizations, PCI and combined diagnostic cardiac catheterization with 
PCI. They proposed 3 quartile DRLs of 83, 193 and 199 Gy.cm2 respectively for 
diagnostic cardiac catheterization, PCI and the combined procedure.  
These initial levels in the US are much higher that the levels proposed in Europe (63) 
and the authors strongly suggest that there is opportunity for improvement in US 
practice. Miller et al. (64) mentions that one possible reason for the high US levels is 
the relative absence of data suitable for reference level determination from the US 
national registry. (70) They conclude by stating that there is no doubt that continued 
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collection of data from US institutions will permit refinement of their initial levels and 
will promote dose optimization efforts.  
 
2.4 DRLs in South Africa 
 
In the South African context limited publications mentioning DRLs exist and no full 
publications were found addressing interventional cardiology reference levels. There 
are some publications defining and proposing DRLs for general radiation 
procedures.  
In 2009 Nyathi et al. (71) potential DRL’s for common radiography projections, 
including chest, pelvis, abdomen, lumbar spine and thoracic spine. They used 
exposure information from 117 patients examined at the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH). Their DRLs were established using the 
3rd quartile entrance surface air kerma values that were derived. Potential DRLs 
were 0.1, 0.22, 2.98, 4.19, 5.3 and 3.28 mGy for Posterior-Anterior (PA) chest, 
lateral chest, Anterior-Posterior (AP) pelvis, AP abdomen, AP lumbar spine and AP 
thoracic spine. These levels compared favourably to similar work done in Brazil (72), 
Iran (73), United Kingdom (12) and the International Atomic Energy Agency (IAEA) 
(74).  
The authors suggest that the lower reference levels may be because of the small 
scale of their project compared to the international multicentre surveys (74), which 
certainly have many more variables in equipment type, operator and radiographic 
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technique. This publication notes the lack of locally available DRLs in South Africa 
and proposed these be used as a starting point for general radiology. (71) 
Engel-Hills & Hering (75) investigated the use of DAP values to calculate DRLs for 
barium enema procedures in the Western Cape of South Africa. Data collected for 
this study included a sample of 50 patients from three departments within the 
Western Cape Province public hospitals.  The DRLs calculated were compared with 
international barium enema dose levels, specifically those of the United Kingdom. 
The third quartile of their distribution was calculated as 84 Gy.cm2 which they 
proposed to be used as an initial reference level for South Africa.  At the time median 
levels compared with those published in the United Kindom showed that South 
Africa’s median was slightly higher, with median doses of 48 Gy.cm2 vs. 41 Gy.cm2.  
Following this article of 2001, Engel-Hills et al. (76) published supplementary work 
on radiation protection in medical imaging in 2006. This work focuses on general 
radiation protection and the critical importance of dose measuring devices, like DAP 
meters, in radiology. They encourage practitioners to take into account the increase 
in demand of radiation protection, and to optimize the exposure of patients, health 
care practitioners and the public. 
The theme of the 2007 South African Association of Physicists in Medicine and 
Biology (SAAPMB) congress was, “Diagnostic Reference Levels”. This certainly 
shows support for the DRL principal among local medical physicists, but 
unfortunately, even today, there is still no national database of exposure information 
or DRLs.  The 2007 SAAPMB congress had as invited speaker Dr Joel Gray who 
has been actively involved in the AAPM, ICRP, NRCP and IAEA committees for the 
development of DRLs worldwide.  Dr. Gray introduced DRLs and the method used 
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from an American viewpoint using the Nationwide Evaluation of X-ray Trends 
(NEXT) survey at this congress. He presented results from this NEXT survey data 
analysis, indicating variations of more than 100 times on one projection across 
America. (77, 78) 
During the SAAPMB 2007 congress Malan et al. (79) presented an audit of patient 
data from patients receiving vascular interventional radiology at the Universitas 
Hospital in Bloemfontein. This study included 1150 patients that had received 
various vascular procedures, including neurological, peripheral vascular, abdominal 
and thoracic investigations.  
Malan et al. (79) showed the procedures recorded with the highest DAP readings 
were Four Vessel Angiography, Uterine Artery Embolization (UAE) and 
Endovascular Artery Repair (EVAR) procedures, which represented 121 of the total 
amount of procedures. The mean DAP values recorded for these three procedures 
were 126, 210 and 350 Gy.cm2. They calculated the mean DAP for all 1150 
procedures as 54.1 Gy.cm2.  
At the same congress, in 2007, Kotze et al. (80) presented research done on 
radiation doses in diagnostic radiology at Groote Schuur Hospital, situated in the 
Western Cape Province of South Africa. They measured entrance skin doses for a 
number of diagnostic examinations that included AP chest, lateral chest, AP 
abdomen, pelvis, AP cervical spine, AP thoracic spine, and AP lumbar spine. For 
these procedures average entrance surface values of 0.31, 1.64, 4, 4.1, 1.3, 3.1 and 
4 mGy were recorded respectively. The authors conclude that it would be possible to 
develop reference levels for common examinations.  
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At the SAAPMB congress of 2015, Makosa & Conradie (81) presented, and 
published an abstract of, a dose audit performed at Universitas Academic Hospital in 
Bloemfontein. Exposure data was recorded for 2014 and DRLs were expressed as 
the 3rd quartile values. They benchmarked their local reference levels in 
interventional cardiology as Coronary Angiography (153 Gy.cm2), Pacemakers (43 
Gy.cm2) and Transcatheter Aortic Valve Implantation (32 Gy.cm2)  
The South African National Department of Health: Directorate Radiation Control 
license conditions (17) dictate that, “the license holder shall: establish a program to 
ensure that the radiation dose administered to a patient for diagnostic purposes is 
optimized.”   
These licence conditions further states that the values of DAP readings shall be used 
for the purpose of optimization of fixed fluoroscopy interventional procedures. These 
licence conditions, although heavily debated in South Africa, create an opportunity 
for radiologists, radiographers and physicists alike to investigate radiation doses, 
optimize and possibly develop local DRL’s. (82) 
This literature review portrays an absence of locally available DRL’s, some 
limitations in international DRL’s and the statements in South African licensing 





CHAPTER 3 METHODOLOGY 
3.1 Interventional Procedure Selection  
 
The X-ray machines identified to be used were all fixed fluoroscopy units used in 
cardiology, hybrid or vascular theatres housed in private hospitals in South Africa. 
The machine and operating theatre type naturally influenced the procedure selection. 
In total, 27 interventional radiology theatres were identified to be included. This 
included imaging equipment built by different equipment manufacturers, which 
mostly included commercially available interventional x-ray machines from the range 
that Siemens and Phillips offers.  
Through consultation with the unit managers, radiographers, cardiologists and 
vascular surgeons, the most common procedures or procedure combinations were 
identified to form part of the study.  Although some interventional radiology 
procedures were included, this study focused on cardiac diagnostic imaging and 
interventions. The cardiology focus was because that was the focus of most of the 
catheterization theatres included in this work. 
Interventional radiology procedures across most disciplines can be broadly classified 
into diagnostic studies and interventions. (83) Typically diagnostic studies are for the 
purpose of diagnosing a problem or the extent thereof. Examples of diagnostic 
procedures are CA, Cerebral Angiography or Renal Angiography etc. The diagnostic 
procedure would normally be simpler and quicker than the intervention, which should 
result in diagnostic procedures having a lower radiation dose. Interventions normally 
follow after a diagnostic procedure, aiming to repair or improve the problem or 
function; examples of interventions are PTCA, Pacemaker Placement or 
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Radiofrequency Ablation, etc. The literature review indicated that in South Africa 
there is a lack of fluoroscopy DRLs for both diagnostic and interventional 
procedures; thus the procedure list aimed to include both classifications.  
The first list of the most common procedures or procedure combinations identified to 
form part of the study is shown in Table 3.1.1(a). Each procedure or investigation 
was assigned a name, “also known as” name and detailed description. Annexure 8.2 
shows the detailed descriptions of each procedure and Table 3.1.1 shows the names 
only. This description and “also known as” name was included to assist 
radiographers and theatre managers with data collection by clearly defining 
procedures types. 
During the course of this study the list was expanded. In January 2013 an additional 
10 procedures were included as this was requested by the clinical teams involved. 
The updated list, which included 24 procedures, is shown in Table 3.1.1(b).  
 
Table 3.1.1: Procedure names for (a) the initial 14 procedures used in Jun – Dec 
2012 and (b) the additional 10 procedures added in Jan 2013. Annexure 8.2 includes 
the detailed descriptions of each of these procedures. 
 
(a) Initial procedures (Jun–Dec 2012) 
 
  






Cerebral Angiography + Interventions 
Cerebral Angiography  Peripheral Angiography 
Renal Angiography  Peripheral Interventions 
CA + Angioplasty (Balloon)  CA + EPS 
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CA + Angioplasty (+ Stent)  CA + EPS + Ablation 
Ablation (RF)  CA + LV + Angioplasty +  2 Stent 
Ablation (RF + Robotic)  CA + LV + Angioplasty +  3 Stent 
EPS  EVAR 
CA + LV function  Permanent Catheters 
CA + LV + Angioplasty  (Balloon)  Paediatric Diagnostic Heart Caths 
CA + LV + Angioplasty (+ Stent)   
Pacemaker (Permanent)   
Pacemaker (Bi Vent)   
TAVI   
Coronary Angiography (CA), Radiofrequency (RF), Electrophysiology Study (EPS), 
Endovascular Artery Repair (EVAR), Trans Aortic Valve Implantation (TAVI) 
 
3.2 Data Collection 
 
In April & May of 2012 the exposure data at four interventional theatres of the larger 
hospitals within the private hospital group were retrospectively reviewed.  The 
purpose of this review was to set up the Microsoft Excel data collection sheets and 
templates to enable either radiographers or unit managers to submit their theatres' 
data easily, accurately and on time.  
Figure 3.2.1 shows a screenshot of the data collection sheet issued to participating 
theatres. Theatres were instructed to include cases done from June 2012. The sheet 
had instructions and other information clearly indicated on the sidebar of the 
Microsoft Excel workbook. An additional worksheet which included the descriptions 
of procedures was added to this workbook. Annexure 8.2 lists these individual 




Figure 3.2.1: Screenshot of a section of the Data collection sheet issued in June 
2012. The participating hospital group name has been removed. 
In an attempt to minimize mistakes, the data collection sheets were locked for 
editing, except for the data required and the drop down lists that were used to assist 
with standardized capturing. The data capturing cycle was decided to be monthly. 
Time periods were clearly indicated on each collection sheet.  
Each interventional theatre had two persons responsible for data capturing and 
submission. Training was given to unit managers and/or radiographers to ensure 
accurate data capturing. All procedures done that didn’t fit one of the 24 procedure 
30 
 
description exactly were excluded from capturing. Paediatric cases were excluded 
except for Paediatric Diagnostic Heart Catheterization which was one of the 24 
procedures investigated. The subsequent patient population captured included all 
cases done which conformed to one of the 24 procedure descriptions and excluded 
only paediatric patients and morbidly obese patients which were defined as having a 
Body Mass Index (BMI) of higher than 40.  
Information to be collected included a procedure description, DAP and screening 
time. (65) The selection of these 27 interventional theatres housed equipment from 
various manufacturers, who expressed DAP in different units of measure; this was 
corrected for in the collection sheet, where all doses were converted to Gy.cm2.  
 
3.3 Dose Area Product (DAP) Calibration 
 
A Dose Area Product (DAP) or Kerma Area Product (KAP) meter is normally 
installed in the collimator assembly, underneath the field shaping device of the 
fluoroscopy unit. The DAP meters used for this study all measure in units of dose 
(Gy) per area, but measurements are displayed in different units of Gy.cm2, 
mGy.cm2 or µGy.cm2.  
The International Atomic Energy Agency (IAEA) Technical Report Series number 
457 (TRS457) (84) recognises that there is an increased need for patient dosimetry 
measurements in diagnostic and interventional radiology and that it is important to 
have traceability of these measurements. The accuracy of a DAP meter, as with any 
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ionisation chamber, may drift over time and routine cross-calibration or verification of 
calibration is necessary. (84) 
The Institute of Physics and Engineering in Medicine Report Number 91 (IPEM 91) 
(85) recommends annual calibration or as per manufacturer specification. An annual 
calibration frequency regime has been widely applied by medical physicists and 
engineers in many countries. (86) The South African X-ray licensing requirements 
specify that DAP meter cross-calibration should be confirmed on acceptance to be 
within the manufacturer specification and at least annually thereafter. (17) In this 
study an annual calibration regime was followed as regulated in South Africa. 
Crawley et al., (86) also emphasizes this need for calibration and suggested that 
annual calibration may possibly be too infrequent for some types of DAP meters. 
They surveyed 41 DAP meters fitted to over and under-couch x-ray tubes for a 
period of five years to assess their long-term stability. Their results showed that 77% 
of the over-couch x-ray tube DAP meters were within 10% accuracy, whereas for the 
under-couch DAP meters only 50% were within 10% accuracy.  
The IAEA TRS 457 (84) provides guidance for the calibration of DAP meters using a 
diagnostic ionization chamber and using another DAP meter, or reference DAP 
meter. Other authors (87, 88)  have shown that using either a diagnostic chamber or 
reference DAP meter produce comparable results with similar uncertainties.  Larsson 
et al. (89, 90) describes optimal calibration methods and deviations in the DAP 
calibration using various methods.  
However, Hetland et al. (87) did note that the reference DAP meter method was 
susceptible to beam quality or energy response. They found up to a 20% difference 
in the DAP meter response for a range of five diagnostic radiation beam qualities 
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between 40 – 150 kV. When the energy range was reduced to 70 – 150 kV, this 
range improved to within 6% for most of the DAP meters evaluated.  
In this work a diagnostic chamber was used to calibrate the field DAP meters, 
because it is accepted as an accurate method and because a reference DAP meter 
was not available to use for this purpose. The IAEA TRS 457 (84) further 
differentiates between an under and over-couch setup for calibration purposes. 
Figure 3.3.1 shows a diagram of the calibration setup reproduced from the TRS 457 
for both orientations.  
 
 
Figure 3.3.1: IAEA TRS 457 (84) DAP meter calibration setup for (a) over-couch 




Equation 3.3.1 is used in TRS 457 to calculate the calibration coefficient,      . The 
readings from the chamber,  
   , and from the KAP meter,     , are used.  The 
nominal beam area is given by     .  In this equation 3.3.1, the factor     
    is the 
calibration coefficient for the reference dosimeter at beam quality    and 
  
   corrects the reference dosimeter reading for the difference in response between 
beam qualities    and  . 
 
         
  
   
  
       
   
  
   
       Equation 3.3.1(84) 
Martin et al. (91) evaluated the use of semiconductor chambers, like the 
Unfors/Raysafe Xi System (92) used in this work, for the purpose of diagnostic 
dosimetry measurements.  
Martin et al. (91) found that, despite being directional, semiconductor systems 
showed small variations in energy response, because of energy compensation 
methods applied by incorporating several elements. These chambers were 
recommended for dose measurements at radiology x-ray energies, but the 
directionality was noted as excluding backscatter from measurement.  
The Unfors/Raysafe Xi detector (92) used in this work employs multiple solid state 
detector elements to automatically determine the beam quality being measured and 
is able to eliminate the need for further beam quality correction in the diagnostic 
energy range.  
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This automatic correction is termed, by the supplier, the chamber’s Active 
Compensation Technology (93) module.  Figure 3.3.2 shows that the beam quality 
response of the Unfors/Raysafe detector, as a result of the active compensation 
technology, is not affected by changing incident beam energy or beam quality.  
 
 
Figure 3.3.2: The beam quality response of the Unfors/Raysafe detector as a result 
of the active compensation technology used. Image reproduced from the Raysafe 
website. (93)  
 
In 2008 Jankowski et al. (94) investigated a simple calibration method on 31 KAP 
meters installed on cardiac and interventional x-ray equipment from various 
manufacturers. They state that KAP meters measure the air kerma (K) integrated 
over beam area (A).  
This is expressed as            by Jankowski. The simplified calibration method 
approximates the integral by measuring and multiplying the air kerma in the centre of 
a field with the known exposed area. This enabled them to calculate a KAP 
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calibration factor for each system. Their results show, taking into account random 
and systematic errors, an uncertainty of  6 % at the 95 % confidence interval using 
this simplified method. (94) 
Toroi & Kosunen (95) state that a DAP calibration within a 7% uncertainty is 
acceptable and indicates a good calibration, and to achieve <5% uncertainty would 
be a very difficult task. They further note that even within a 10% uncertainly the 
calibration will sufficiently cover clinical radiation qualities used in fluoroscopy. Terini 
el al. (88) showed a 5% variance using a reference DAP meter technique and a 
3.5% when using a diagnostic chamber for calibration.   
The cross-calibration method utilised in this work is based on the methods of cross 
calibration for DAP/KAP meters explained in the TRS 457 (84) and on the infield 
simplification used by Jankowski et al., (94) described earlier in this chapter. Each 
medical physicist was responsible for the calibration of the x-ray machines within 
their regions and was supplied with a calibration procedure and calibrated 
Unfors/Raysafe (92) dose meter. The equation used to calculate the calibration 
coefficient is shown in equation 3.3.2.  
This equation expresses the simplified method used by Jankowski et al. (94) in the 
format as given by the IAEA TRS report 457. Equation 3.3.2 takes into account the 
Active Compensation Technology (93) used in the Unfors/Raysafe detectors, which 
makes the measurement device not sensitive to energy/beam quality changes in the 
diagnostic energy range. This enables the removal of detector beam quality 
corrections,    
    and   
   , as stated in equation 3.3.1. The terms used in this 




         
  
   
  
             Equation 3.3.2 
 
In this work all DAP meters were calibrated before the start of the data collection and 
periodic cross-calibration was performed as required during its course. In cases 
where calibration was not possible, a correction factor was used to correct the 
measured DAP value for each procedure.  
Dose measurements were done using four sets of Unfors/Raysafe Xi range (92) of 
measuring devices, designed to perform measurements in diagnostic beam qualities. 
These dose meters were all calibrated with traceable calibration certificates from 
laboratories with ISO/IEC 17025 accreditation (96).  
Two methods were followed to calibrate (and /or verify) the DAP meters. A cross-
calibration or verification of a DAP meter requires the accurate field size and a dose 
measurement at the same Source to Surface Distance (SSD). Which technique was 
used was at the discretion of the medical physicist, depending on the type of 
interventional machine, its radiation field shaping capabilities and the type of DAP 
chamber.  
1. The first DAP calibration method was used when interventional machines 
have limited field shaping capabilities as often seen on older equipment using image 
intensifier fluoroscopy technology. This procedure is also accurate on most machine 
types and requires the use of a fluorescent screen, copper sheet and a calibrated 
dose meter. The interventional unit gantry is rotated to 90 degrees and a 2 mm 
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copper sheet is placed on the intensifier or flat panel (image detector). A diagram of 
this setup is shown in figure 3.3.3. 
The purpose of the copper is to increase the X-ray tube output which decreases the 
uncertainty in measurement and improves visualization of the X-ray field on the 
fluorescent screen. The fluorescent screen is placed between the X-ray tube and 
copper plate. When this setup is exposed using fluoroscopy in a room with low 
background light, the radiation field size is seen on the fluorescent screen as visible 
light which enables the measurement of the radiation field dimensions using a ruler. 
The radiation field is normally either square or rectangular in shape and the size of 
area can be calculated by multiplying together the length and width of the field sides. 
The calibrated Unfors / Raysafe dose meter is positioned directly on the fluorescent 
screen in the centre of the field, to measure a point dose in Gray (Gy). The TRS457 
(84) notes that a 200 mm distance is recommended between the object and the 
dosemeter to avoid possible backscatter radiation. The Unfors / Raysafe Xi detector 
used for measurements is suitably shielded for backscatter (91, 92) and may be 
placed directly on top of the attenuating material. The dosimeter is positioned in the 
beam centre and the field collimated around the chamber.  
 
2. The second method is used when interventional machines have good field 
shaping capabilities, as seen on most flat panel detector technology, where the 
collimator can be easily adjusted to conform to the visualised object’s dimensions. 
The precise square field size at the measuring point is important. (e.g. 10 cm X 10 
cm) This field size can be obtained by using the Normi 4 Flu phantom grid and using 
fluoroscopy to set the field size. This field size is given in units of cm2. No 
magnification should be set when determining the field size. 
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After the field size has been set, either the DAP meter must be reset or the 
accumulated reading must be noted for subtraction when the calibration verification 
calculation is performed. 2 mm copper must be added on the image intensifier to 
increase the tube output, which will decrease the uncertainty in the dose 
measurement. The dose is measured by exposing the setup continuously for 
approximately 20 - 30 seconds. 
The DAP is calculated by multiplication of the squared field size and the point dose. 
The result is in a value that is the product of dose and area. This is divided by the 
time to obtain the unit as dose X area per time. The displayed DAP reading from the 









3.4 DRL Calculation and Statistics 
 
The time period for this study stretched from June 2012 to December 2013, which 
was split into six quarters. Quarter 3 2012 (Q3 2012) included data from June-
September 2012 and Quarter 4 2012 (Q4 2012) included October-December 2012.  
In a similar fashion 2013 was spilt up into four quarters, namely, January-March (Q1 
2013), April-June (Q2 2013), July-September (Q3 2013) and October-December (Q4 
2013).  
The DAP readings recorded at the imaging modalities were used as primary 
measurements and averages and DRLs (Gy.cm2) were calculated from these. The 
exposure data received is best presented when using a histogram curve, which 
clearly shows the population frequency in different DAP (Gy.cm2) bins. This is 
consistent with other authors using similar methods to evaluate the distribution. (64)  
There are different ways to define reference levels; in this study the 3rd quartile of the 
distribution was used, which was calculated for each type of procedure and for each 
quarter. The 3rd quartile DRL simplifies comparisons with work published from other 
countries.  (97, 98) Further statistical analysis of the DAP distribution included 







3.5 Optimization & Feedback  
 
The term optimization and more specifically dose optimization goes alongside the 
consideration of acceptable or sufficient clinical image quality during a diagnostic 
procedure or intervention. Good radiology techniques aim to provide the doctor with 
acceptable image quality depending on the type of exam and it considers radiation 
dose when doing this. Acceptable image quality describes what information is 
required as a minimum for the doctor to diagnose accurately or to perform a 
procedure safely. Conversely excessive image quality describes images where 
surplus information is present that is not necessary for the type of procedure. 
Excessive image quality can lead to unnecessarily high radiation doses to patients 
and should be avoided.  
When the term optimization is used in this work it aims to find the balance between 
acceptable image quality and radiation dose. When optimization is used to describe 
changes to the radiographic technique it can be assumed that sufficient image 
quality was the goal and that the technique changes did not result in an 
unacceptable loss of image quality.   
Feedback from the data collection process and the optimization attempt was 
considered very important throughout the period of data collection, especially 
feedback to participants regarding possible optimization or lack thereof. The method 
of feedback was decided to be a newsletter that was sent to all stakeholders in the 
private sector interventional theatres that participated.  
The stakeholders included, among others, theatre unit managers, registered nurses, 
radiographers, medical physicists, hospital safety officers, hospital administrators, 
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specialist doctors and members of the private hospital board of directors. The 
information shared with stakeholders included their mean DAP values for common 
procedure types and comparisons to their neighbouring hospitals, as well as 
comparisons to published international references levels from Europe and 
elsewhere. (63, 64, 74) Other authors have shown that complex technique 
investigations, adjustment and knowledge of a possible high dose used have shown 
to improve dose usage. (23, 99)  
In South African interventional theatres the radiographer is considered the trained 
specialist in radiographic technique and safety. The cardiology scope of practice 
does not allow x-ray unit operation without a radiographer present and for these labs 
that is the status quo.  The normal practice in the labs partaking in this study allows 
screening by either the radiographer or specialist doctor, depending on the 
practitioner’s preference. Generally the radiographer will set up and control the 
technique setting, whilst the specialist engages fluoroscopy when required. Arthur et 
al. (100) showed that techniques where cardiologists engage the fluoroscopy 
exposure may reduce dose compared to when radiographers engage the 
fluoroscopy exposure on instruction from the specialist doctor. The decision of who 
has their foot on the fluoroscopy pedal and whether that impacts dose was not 
assessed during this work. 
It was a conscious decision to share hospital mean values with them in these 
newsletters, and not the 3rd quartile DRLs, considering that dose optimization was 
the goal.  
During the preliminary session of the SAAPMB 2007 congress, Dr Joel Gray said, “I 
am uncomfortable if I see some of the reference levels being published and I am 
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uncomfortable seeing the levels published by the AAPM. I know we can be much, 
much better than these levels. Where should we be in terms of dose? From what I 
have seen, if you have good medical physics support at your facility, you should be 
operating at less than 50 % of the reference levels. Think about that, it means you 
should be operating below the median exposure. That doesn’t make sense. How can 
everyone be below the mean level? Simply because the reference values and 
average values are too high to start with. I am challenging you to look at the 50 % of 
the reference level as the target.” (77) 
Gray then concludes this preliminary session on the how and why of reference levels 
by saying, “First and foremost, we have to look at optimized image quality and dose. 
Again my challenge to you, let’s look at the 50 % DRL as the goal for our own 
departments.”  (77) 
The optimization method used in this work, writing educational newsletters as 
feedback and disclosing the 50% DRL to participants, were done taking into 
consideration that our doses were high and had the aim of optimization in mind.  
The communication letters were aimed to educate, encourage and enable 
interventional theatres to track their performance and possible optimization or lack 
thereof. Where high doses frequently occurred the focus was to distribute the IAEA 
radiation protection posters (101) and provide radiation protection training to staff.  
It was realised that optimization may possibly require funding, if equipment 
upgrading or replacement were to be identified as the likely cause of centres 
exceeding reference levels. This was the main reason why hospital administrators 
and members of the board of directors were included in the communication. 
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It is noteworthy to mention that, during this period of DRL data collection and 
optimization, improvements were made to the incident management system. These 
improvements defined and quantified possible radiation incidents for individual 
patients when there was a likelihood of exceeding the threshold dose for skin 
erythema. These incident dose levels are by definition doses to individuals and not 
that of populations or groups of patients as found in the description of the DRL. 
Considering the large variability in complexity of interventional fluoroscopy 
procedures and the resulting radiation dose it is likely that theatres with optimized 
techniques may exceed these incident levels. These incident levels are for individual 
patients and should not be confused with DRLs.  
Trianni et al. (102)   proposed that investigation levels be set as low as 140 Gy.cm2 
for cardiac cases. The IAEA radiation incident management system Safety in 
Radiological Procedures (SAFRAD) (103) indicates 500 Gy.cm2 as an investigation 
level. Neofotistou et al. (30) proposed a DAP skin reaction investigation level of 300 
Gy.cm2 for interventional cardiology procedures as this could likely cause a skin 
reaction.  
For this work fluoroscopic patient doses exceeding 300 Gy.cm2 were required to be 
reported for handling by the responsible medical physicist as an incident dose level. 
(104) This level is lower than that proposed by the IAEA, but considering the smaller 
field sizes often used during cardiac procedures this was considered a more suitable 
investigation level.  
The incidents were graded depending on possible severity of the resulting skin 
reaction and were handled either by electronic correspondence or site visits. The 
incident grading was further used to guide the responsible physicist in management 
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and peak skin dose estimation. These incident reporting requirements reinforced the 
same radiation protection principles as the radiation dose optimization system. 
 
3.6 Null Hypothesis 
 
The research question introduced in this work has two parts. Firstly, “Are radiation 
doses used in South African private healthcare interventional laboratories high 
compared to those published internationally” and secondly, “will establishing dose 
reference levels optimize the doses used?” 
The null hypothesis will also have two parts. Firstly, to establish whether the DRL 
calculated per procedure is significantly higher than DRLs published internationally. 
The literature review portrayed some variation in published doses for the different 
procedures. The mean and standard deviation are sufficient to evaluate if South 
African DRLs compare well to international levels. If the South African DRLs fall 
within a range of the international DRL mean (1 SD), then this should prove that 
local reference levels are not high in comparison. If South African doses fall outside, 
or are higher than, the range of international DRLs mean (1 SD) this would indicate 
that local doses are elevated compared to international levels. This is the alternative 
hypothesis for the first part of the research question.  
The second part of the proposed null hypothesis (    attempts to evaluate if there 
was optimization of radiation usage. Has the DRL improved with sufficient degree of 
statistical significance to prove there was dose optimization?   
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Equation 3.6.1 formulates the null hypothesis. The symbols     and    represents the 
2012 Q3 (baseline) and 2013 Q4 (last quarter) DAP distributions respectively.  
 
                   Equation 3.6.1 
 
If the null hypothesis is proven correct, it affirms that an insufficient degree of 
statistical evidence exist to support the relevance of differences in the means of    
and   . Affirmation of the null hypothesis will mean no optimization can be proven. If 
the null hypothesis is rejected the alternative hypothesis (    , expressed in equation 
3.6.2, stands. 
 
                 Equation 3.6.2 
 
If the alternative hypothesis stands it affirms that a sufficient degree of statistical 
evidence exist to support the relevance of differences in the means of    and   . 
Affirmation of the alternative hypothesis, or rejection of the null hypothesis, will mean 
that optimization was proven.  
The aim of optimization is to lower doses and improve the DRL over time. It is 
sensible to include a degree of measure in the null hypothesis to support the amount 
of optimization realised. The null hypothesis for the optimization part of the research 
question is formulated as equation 3.6.3, where   is the    mean DAP reading and 
   is the    mean DAP reading.  
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Equation 3.6.4 represents the alternative hypothesis. Using this will enable the 
acceptance or rejection of possible optimization measured for each procedure type 
as the differences of means. 
 
                         Equation 3.6.3 
                         Equation 3.6.4 
 
Fagerland et al. (105) found that the most common approach to test the null 
hypothesis in medical research is the statistical independent samples t-test. They 
(105) add that it is an appropriate test if the distribution under evaluation follows a 
normal distribution curve or Gaussian distribution. This test is used when attempting 
to evaluate a hypothesis using the significance of differences in means acquired 
from normally distributed populations of data for two independent groups.  
The literature review showed that it can be expected, that the distribution of DAP 
readings will likely have a positively skewed shape. (64) This is unfortunate because 
the statistical analysis of the distributions using independent samples t-test requires 
the data to have a normal distribution. (105) 
This problem of non-normality of a distribution has been noticed by various authors 
(106-109) across the medical field. One solution to overcome the non-normality is 
using the Log10 of the population values before statistical analysis. (106-109) The 
DRL dataset is sufficiently large to allow some degree of freedom in suitability of the 
t-test and if the Log10 of the DAP distributions present as a normal distribution, then 
the t-test is appropriate to evaluate the hypothesis. Aroua et al. (97), applied this 
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method of using the Log10 in their advice for setting up DRLs at a national level in 
Switzerland for a variety of radiographic procedures.  
Middleton (110) proposed that the degree of normality in the distribution, used to 
assess the aptness of the t-test, can be evaluated using a normal distribution 
probability graph. If the normal distribution probability graph can be adequately fitted 
using a linear equation, then the appropriateness of the t-test for the sample is 
justified. (110) 
This method will be used to evaluate, firstly, if the Log10 of the distribution indicates 




CHAPTER 4 RESULTS  
4.1 DAP Calibration 
During the course of 2012 the calibration of each DAP meter installed at the 27 
participating x-ray units was verified by the responsible medical physicist in each 
region. This resulted in the initial calibration factors used. The initial factors are 
shown in Table 4.1.1 in the column Q3 2012. 
As the programme progressed DAP calibrations were done as required for the 
purpose of annual quality control or in the event of major repair or replacement of a 
machine. The calibration factors for the other quarters, as applicable, are shown in 
columns Q4 2012 – Q4 2013. Machine number 22 was replaced during Q1 of 2013. 















1 1.36 --- --- 1.32 --- --- 
2 0.99 --- 0.98 --- --- --- 
3 0.95 --- --- 1.04 --- --- 
4 0.88 --- --- --- 1.00 --- 
5 1.09 1.10 --- --- --- --- 
6 0.97 0.91 --- 0.94 --- --- 
7 1.00 0.86 --- --- --- 0.85 
8 1.18 --- --- 1.18 --- --- 
9 1.09 0.98 --- --- --- --- 
10 0.98 1.09 --- --- 1.10 --- 
11 1.01 0.97 --- --- --- --- 
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12 1.14 1.10 --- --- --- --- 
13 0.93 --- --- --- 0.91 --- 
14 0.92 --- --- --- 0.90 --- 
15 1.02 --- --- --- 1.00 --- 
16 1.14 --- --- --- --- 1.12 
17 1.02 --- --- --- 0.97 --- 
18 0.94 --- 0.95 --- --- --- 
19 1.18 --- --- --- 1.18 --- 
20 1.05 --- --- --- 1.06 --- 
21 0.95 1.01 --- --- --- --- 
22 0.89 --- 0.96* --- --- --- 
23 1.05 --- --- --- 0.98 --- 
24 1.00 1.10 --- --- --- --- 
25 0.88 1.00 --- --- --- --- 
26 0.89 0.83 --- --- --- --- 
27 1.10 --- --- --- 1.11 --- 
 * (Replaced Unit)     --- (No change) 
 
4.2 Data Dissemination 
 
Patient DAP data was recorded in 6 quarters which resulted in a total of 20415 
procedures. Each of the 27 theatres was assigned a random number for purposes of 
anonymity which remained unchanged in the results and discussion sections. The 





Figure 4.2.1: A map of South Africa showing the approximate position of the 27 
interventional theatres included in this study. The red markers indicate the 
approximate position of each theatre. This illustration is an edited version of online 
content. (111) 
Table 4.2.1 shows all the data recorded for each procedure type and includes the 
mean DAP value calculated per quarter. The procedures with a high incidence were 
CA, CA + LV, CA + PTCA + 1 Stent, PPM, PPM Biventricular and Radiofrequency 
Ablation.  These procedures accounted for 76% of the total amount recorded and are 
highlighted in bold in Table 4.2.1. CA accounted for 3911 cases, CA + LV for 7547 
cases, CA + PTCA + 1 Stent for 1885 cases, PPM for 1175 cases, Biventricular PPM 
for 280 cases and Radiofrequency Ablation for 675 cases respectively.  
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It was decided to investigate, in detail, these 6 most common procedures (2 
diagnostic, 4 interventions) for the purpose of this thesis. Furthermore it was decided 
that because dose is the vital parameter featuring in both the aim and hypothesis of 
this work and because of the large amount of information in this dataset that the time 
parameter would not be further analysed. The literature review showed many studies 
referring to time, but the majority of authors found dose only to be sufficient which 
supports this decision. The detailed results for these six procedures are shown in 
subsections 4.2.1 – 4.2.6. Each of these subsections comprises of a table and two 
types of graphs explained below: 
 
1. Tables 4.2.1-6.1 introduces each subsection and includes the mean, 1st 
quartile, 3rd quartile, standard deviation and inter-quartile range for each 
subsequent procedure and for every quarter. 
2. Figures 4.2.1-6.1 (a-f) shows the data distribution for the six most common 
procedures displayed in a histogram each per quarter. All DAP values greater 
than 300 Gy.cm2 were binned in to the 300 Gy.cm2 bin. It is also quite clear 
from the histograms that the data is skewed and does not follow a normal 
distribution. 
3. Figures 4.2.1-6.2 (a-b), Figures 4.2.1-6.3 (c-d) and Figures 4.2.1-6.4 (e-f) 
displays the mean DAP values, for the six studies selected, for each hospital 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.4 Radiation Dose Optimization 
 
4.4.1 Null Hypothesis - First Part 
 
The first part of the null hypothesis aimed to determine if the DRL calculated per 
procedure is higher compared to international levels. The mean international level 
(+/- 1 SD) was proposed to evaluate this hypothesis. Should the DRLs in this study 
fall within a range of the international DRL mean (+/-1 SD), then this should prove 
that local reference levels are not high in comparison. If DRLs fall outside, or are 
higher than, the range of international DRLs mean (+/-1 SD) this would show that 
local doses are elevated compared to international levels. 
Table 4.4.1.1 shows the reference levels of various international studies. These 
levels are mostly 3rd quartile values. Where some authors only disclosed the mean 
DRL values they were used. The literature review portrayed wide variation in 
published DRLs for the different procedures which was confirmed by the SD of most 
procedures investigated. In Table 4.4.1.1 the international mean is the average of 
the published levels displayed per procedure type. The international mean + 1 SD is 
the international mean value with the addition of one SD calculated for the range 
found in these different publications. The SD for Biventricular PPM could not be 













































































































































































































































































































































































































































































































































































































































































































4.4.2 Null Hypothesis - Second Part 
 
The second part of the null hypothesis aimed to evaluate if optimization of radiation 
usage was improved or not. The amount of optimization was investigated and 
expressed as a percentage change in the 3rd quartile DRL per quarter in Table 
4.4.2.1. The percentage change shown in this table is expressed as a percentage 
difference for each quarter compared to the baselines set in Q3 2012. 
Table 4.4.2.1: The amount of optimization expressed as a percentage of the baseline 
3rd quartile DRL values for each of the six procedures investigated. The symbol (↓) 
indicates the 3rd quartile value has reduced compared to baseline, whereas the 
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Another important measure of the second hypothesis is proving that a sufficient 
degree of statistical significance exists to support the optimization calculated.  As 
explained in the method the t-test, proposed for evaluation, is only useful for normal 
distributions. It is clear in section 4.2 that all the DRL graphs are not normally 
distributed and the t-test cannot be applied. The logarithm base 10 (Log10) of the 
DAP data may correct the distributions for the purpose of t-test compliance. Should 
the Log10 of the distribution indicate normality then the t-test can be used for the 
evaluation of the null hypothesis.  
The Log10 was applied to the data and the amount of normality was assessed using 
a normal probability plot shown in Figures 4.4.2.1-2. The normal probability plot was 
prepared using the method described by Middelton (110). The method requires that 
the Log10 DAP data be sorted in ascending order and plotted on the y-axis vs. the 
normality score on the x-axis as shown in Figures 4.4.2.1-2. In these graphs the 
normality score is used to estimate the position of each Log10 DAP value in relation 
to the ideal location of a standard normal distribution. If the normal probability plot 
can be adequately fitted with a linear curve, then the data is normally distributed and 
the t-test suitable. 
The Log10 of the DAP data does normalize the distribution as indicated in the normal 
distribution probability graphs. The R2 value for all six procedures was > 0.95 which 




Figure 4.4.2.1 (a-c): The normal distribution probability graphs for (a) CA, (b) CA + 
LV and (c) CA + PTCA + 1 Stent. 
y = 0.4005x + 1.5915 

















a) CA 2012 Q3 
y = 0.4x + 1.637 

















b) CA + LV 2012 Q3 
y = 0.325x + 2.0521 


















c) CA + PTCA + 1 Stent 2012 Q3 
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Figure 4.4.2.2 (d-f): The normal distribution probability graphs for (d) PPM, (e) Bi-
vent PPM and (f) RF Ablation.  
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d) PPM 2012 Q3 
y = 0.5364x + 1.8397 


















e) Bi-vent PPM 2012 Q3 
y = 0.581x + 1.6004 


















f) RF Ablation 2012 Q3 
90 
 
Since the Log10 DAP data is normally distributed, the t-test may be applied. The t-
test checks whether the mean of two samples is significantly different. The two tailed 
t-test is the more stringent one and is recommended when there is no certainty if the 
change is one directional.(122)   
 The output of the two-tailed t-test is in terms of a T statistic (T Stat), T critical statistic 
(T Crit) and the Probability value (P). The Tstat and the Tcrit are test statistical values in 
units of standard error that measure the difference between and observed statistic 
and its hypothesised parameter. If the Tstat is larger in value than the Tcrit the 
hypothesis may be rejected which would mean, for this study, that optimization was 
enhanced. 
The P-values describe statistical significance and generally a P-value smaller than 
0.05 is accepted as being statistically significant.  (122) The Alpha value, also known 
as the significance level, was set to 0.05 for all the t-test performed. This allows a 
5% risk of a false positive result using the P-value calculation. A P-value of less than 
0.05 would reject the hypothesis and show that optimization was improved. Should 
the P-value exceed 0.05 the hypothesis cannot be rejected which indicates that 








Table 4.4.2.2: The results of the individual samples t-test performed on the Log10 of 
DAP values for the distributions of each procedure type. For each of the six 
procedures investigated the hypothesized difference in mean, T statistic, critical T 
statistic, Probability value (P) and the alpha (α) value is shown. The symbol (↓) 
indicates the 3rd quartile value has reduced from the baseline value. 
 % DRL 
         
=      
T Stat T Crit P α 
Reject 
         
        
CA ↓13 0 3.57 1.96 0.0004 0.05 Yes 
        




↓ 9 0 2 1.97 0.0470 0.05 Yes 
        PPM ↓13 0 2.08 1.97 0.0388 0.05 Yes 
        
Bi-vent 
PPM ↓19 0 0.89 2.02 0.3788 0.05 No 
        




CHAPTER 5 DISCUSSION 
 
Table 4.1.1 shows the DAP calibration factors used for all x-ray machines during the 
investigation period. For most machines the calibration factors had little influence in 
the resulting mean doses, but for some units the DAP calibration factors change their 
doses with more than 10% for some months. These units include theatre numbers 1, 
4, 7, 19, 22, 25 and 26. When calibration correction factors changed during the 
course of the investigation, they were updated in the calculation spread sheets for 
the months following the quality control where the new factor was calculated. The 
mean DAP calibration correction factor for all x-ray units during all six quarters was 
1.02 (0.1). 
The DAP readings were collected and evaluated for the six quarters and the amount 
and mean DAP values per procedures is shown in Table 4.2.1. In total 20415 
procedures were recorded from June 2012 – December 2013. The procedures with 
high incidence that were chosen for detailed evaluation were CA (n = 3911), CA + 
LV (n = 7547), CA + PTCA + 1 Stent (n = 1885), PPM (n = 1175), biventricular PPM 
(n = 280) cases and Radiofrequency Ablation (n = 675).  These six procedures 
accounted for 76% of the total number of procedures recorded and thus is an 
adequate sample to investigate in detail. 
Biventricular PPM, despite the lowest incidence in the selection, was also included 
for detailed evaluation alongside the normal PPM placement. The literature review 
indicated limited information available regarding biventricular PPM, and the inclusion 
and comparison of PPM with biventricular PPM may be worthwhile investigating. 
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A high number of CA + LV + PTCA + Stent procedures were also done during this 
period. The CA + LV + PTCA + Stent data included many variables and was further 
divided during the course of the study depending on the amount of stents. This 
change in procedure description obviously voided the usefulness of the baseline and 
thus CA + LV + PTCA + 1, 2, 3 Stent were excluded from the six procedures 




CA was one of the procedures selected for detailed analysis and Table 4.2.1.1 
shows the case number, mean, standard deviation and different quartiles of the CA 
DAP distribution for all six quarters. A total of 3911 CA procedures were included 
and Table 4.2.1.1 and the mean values were 61, 45, 48, 44, 49, and 47 Gy.cm2 for 
the quarters starting at Q3 2012 up to Q4 2013. The calculated DRLs for the same 
period were 66, 56, 64, 53, 58 and 57 Gy.cm2. 
The DRL histograms for CA are shown in Figure 4.2.1.1 and clearly have a positively 
skewed distribution toward the higher dose bins. As confirmed during the literature 
review, this is the expected distribution for interventional DRL histograms. (64) The 
shape of the DRL histogram curve appears similar for all six quarters, but with less 
frequency in high dose components and a slight movement of the curve toward lower 
dose bins were noticed. This movement, seen graphically, is consistent with the 
reduction in 3rd quartile DRL values seen in Table 4.2.1.1. The number of incident 
level doses, of larger than 300 Gy.cm2, recorded for CA reduced from 16 to 6, 4, 2, 7 
and 3 during the six quarters starting at Q3 2012 up to Q4 2013. 
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During the six quarters for CA it is clear that the standard deviation and inter-quartile 
range reduced. This is shown in the last rows of Table 4.2.1.1. The SD reduced from 
76 to 48 Gy.cm2 and the IQR reduced from 43 to 36 Gy.cm2. Initially, graphically, the 
wider spread of the DAP baseline histogram is apparent in Figure 4.2.1.1 and the 
larger SD and IQR is consistent with the Figure. The reduction in SD and IQR for CA 
shows that the amount of variation in the dataset decreased during the period of data 
collection and dose optimization. 
The mean CA DAP values for each theatre and for each quarter are shown in 
Figures 4.2.1.2-4. The dose optimization attempt focussed on theatres where their 
mean values consistently exceeded the mean value calculated for all participating 
theatres. This was termed the group mean value and can be seen in Figures 4.2.1.2-
4 as the horizontal line. 
When evaluating Figures 4.2.1.2 (Q3 & Q4 2012) it is very clear that hospital 12 
consistently, and with a large margin, exceeded the group mean value for CA. The 
mean CA DAP values for theatre 12 were 147 and 151 Gy.cm2 for Q3 and Q4 2012. 
In the same period the group mean DAP values for CA were 61 and 45 Gy.cm2, 
which is much lower. It was soon realised that the high mean doses recorded for CA 
procedures at theatre 12 for Q3 & Q4 2012 were unfortunately not isolated to only 
CA procedures.  
The CA + LV procedures for theatre 12 also showed that their mean doses were 
significantly elevated compared to the group mean. This is illustrated in Figure 
4.2.2.2. The mean CA + LV DAP values for theatre 12 were 122 and 129 Gy.cm2 for 
Q3 and Q4 2012 and in the same period the group mean DAP values were 65 and 
58 Gy.cm2.  
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The other procedures followed suit and theatre 12’s doses for CA+PTCA+1 Stent 
and PPM procedures seen in Figures 4.2.3.2 and 4.2.4.2 are high compared to each 
respective group mean DAP level. Theatre 12 didn’t perform many biventricular 
pacemakers or radiofrequency ablation procedures.  
This high dose trend observed for theatre 12 was a matter of concern to the 
responsible medical physicist. Closer investigation into the radiographic technique 
and appointments with each of the radiographers highlighted that the resident 
cardiologists only use fluorography to perform their cases. This decision to 
exclusively use fluorography was taken by the cardiologists, because they were not 
happy with the image quality during normal fluoroscopy screening. The cardiologists 
motivated this decision, because of the age of the machine and they were not willing 
to risk making a clinical mistake because of poor image quality. The radiographers 
knew and advised the cardiologists that this was a high dose technique, but were 
unsuccessful to cause any changes. The quality control results of the X-ray machine 
housed in this theatre was reviewed and it showed, despite its age, that the machine 
was operating within the allowed dose and image quality limits as regulated (17) in 
South Africa. Poor decisions regarding radiation usage reinforces, for South Africa, 
the opinion of Vlietstra et al. (15), and  Koenig et al. (3), that there is a lack of 
radiation safety training among specialists like cardiologists.  
The poor radiographic technique explained the high doses recorded in theatre 12. 
Immediately, upon this realisation, this was addressed with the hospital 
administrators, cardiologists and radiographers. Firm instruction from the private 
medical physicists regarding dose reduction was given and this was supported by 
the hospital administrators and radiographers. The cardiologists were unhappy with 
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this instruction and emphasized that the problem is not their technique, but 
equipment related.  
The instructions detailed that fluorography should not be used routinely for screening 
purposes, but only when essential and when image recording is required. 
Additionally, multiple radiation optimization and safety training sessions were held for 
the radiographers and theatre staff. The IAEA optimization posters (101) were also 
explained and distributed during these training sessions.  
The balance between image quality and dose was highlighted here. If specialists are 
untrained on the concept of dose, they lean towards achieving the best image 
quality. During the SAAPMB 2007 opening session Gray (77) said, “Noise is good” 
and ,“As long as dose is good and image quality is good, I am not worried about 
other factors like mA, kV, filtration, etc.” To these doctors the concept of “noise is 
good” was unfamiliar and hard to accept. 
The correction of this poor technique and the optimization training resulted in theatre 
12’s mean CA dose being reduced by 44% and CA +LV by 34% from baseline mean 
doses in Q4 2013. This was encouraging, that even for ageing technology and for 
largely un-cooperating specialists, dose optimization seemed to eventually lower 
doses. The radiation incident investigations and management assisted with dose 
optimization, especially for theatre 12, because the responsible medical physicist 







5.2 CA + LV 
 
Another procedure analysed in detail is the 7547 CA + LV cases recorded. Table 
4.2.2.1 show the amount of CA+LV cases, mean, standard deviation and different 
quartiles for the CA + LV distribution for all six quarters. CA + LV showed a reduction 
of mean DAP and a reduction in 3rd quartile DRL from 65 to 51 Gy.cm2 and from 77 
to 63 Gy.cm2 respectively. The SD and IQR for CA + LV decreased from 71 to 48 
Gy.cm2 and from 51 to 38 Gy.cm2 respectively. This is similar to the trend observed 
for CA procedures without LV function tests included.  
The CA + LV DRL histograms in Figure 4.2.2.1 also show a positively skewed 
distribution, as with CA. The reduction in mean, DRL, SD and IQR is reinforced by 
the slight movement of the distribution graphs towards lower dose bins. The number 
of incident level doses of larger than 300 Gy.cm2, recorded for CA + LV reduced 
from 22 to 16, 7, 3, 8 and 4 during the six quarters starting at Q3 2012 up to Q4 
2013. 
The mean CA + LV DAP values for each theatre and for each quarter are shown in 
Figures 4.2.2.2-4.  On Figure 4.2.2.2 (a) the baseline CA + LV values are shown. In 
this Figure theatres 12, 15 and 22 had mean doses that were considerably higher 
than the group mean. High doses for theatre 12 CA + LV have been discussed. 
Theatre 15 recorded their baseline CA + LV mean DAP as 185 Gy.cm2. During the 
other quarters their CA + LV dose ranged between 22 – 43 Gy.cm2, which is better 
than and surely comparable to the group mean CA + LV DAP. This high baseline for 
theatre 15 may be attributed to the sad passing on of one of the hospital's 
cardiologists, which resulted in a young doctor taking over his case load. These may 
be indicative of the new cardiologist becoming familiar with the theatre and local 
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procedures. Theatre 22 is a combined cardiac and vascular unit which does not 
perform many cardiology cases. This is probably the reason for the high CA + LV 
baseline, as cardiology is not their clinical forte.  
Considering that CA+LV is the normal CA procedure, which includes 
ventriculography, where typically ejection fraction, stroke volume and cardiac output 
is measured, it can be expected to have a higher mean dose than CA alone. The 
literature review found very few articles differentiating between CA with and without 
the inclusion of LV. Fazel et al. (123) described diagnostic CA and resting heart LV 
quantification as both being medical procedures that have a large contribution to 
populations’ effective doses. Padovani et al. (68) published a CA reference level with 
LV function included of 70 Gy.cm2. This is marginally higher than our Q4 2014 DRL 
for CA+LV of 63 Gy.cm2.  
The reference level calculated for both baseline and current data indicates that the 
addition of LV function increases the dose needed compared to a normal CA. This 
was consistent for all quarters: the observed CA + LV mean DAP was higher than 
that of CA only. Respectively, for the 6 quarters, the mean DAP value of CA + LV 
was 3.9, 12.8, 0.8, 7.4, 8.5 and 4.1 Gy.cm2 higher than that of CA. This is shown 
graphically in Figure 4.3.1.  
On average the mean CA + LV DAP was 6.3 Gy.cm2 higher than CA and the 3rd 
quartile DRL was on average 9.2 Gy.cm2 higher. Clark et al. (124) noted that they 
found, in their study of 1337 cardiac procedures, that LV function increased CA 
mean doses by an average of  6 Gy.cm2. This was attributed to the extra screening 
required to perform the ventricle tests like ejection fraction, stroke volume and 
cardiac output. The results of Clark et al. (124) noting the difference in CA and CA + 
LV are consistent with this study. 
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5.3 CA + PTCA + 1 Stent 
 
CA + PTCA + 1 Stent was also selected for detailed analysis and Table 4.2.3.1 
shows the case number, mean, standard deviation and different quartiles of the 
distribution of all six quarters. A total of 1885 CA + PTCA + 1 Stent procedures were 
included and in Table 4.2.3.1 the mean dose values were 147, 118, 130, 131, 130, 
and 137 Gy.cm2 for the quarters starting at Q3 2012, up to Q4 2013. The calculated 
DRLs for the same period were 192, 157, 167, 164, 179 and 176 Gy.cm2. 
The DRL histograms for CA + PTCA + 1 Stent are shown in Figure 4.2.3.1 and do 
not appear as neatly positively skewed compared to the distributions of CA and CA + 
LV. This is likely because the procedure includes larger variations in complexity and 
difficulty. The variation is quantified using the SD and IQR shown in Table 4.2.3.1. 
The CA + PTCA + 1 Stent mean SD and IQR for the six quarters are 105 Gy.cm2 and 
112 Gy.cm2 respectively. These variation quantifiers are more than double those of 
CA and CA + LV procedures.    
The shape of the DRL histogram curve appears similar for all six quarters and 
graphically no lower dose shift in the distribution is apparent. The number of incident 
level doses of larger than 300 Gy.cm2, recorded for CA+ PTCA + 1 Stent reduced 
from 39 to 14, 23, 22, 20 and 14 during the six quarters starting at Q3 2012 up to Q4 
2013. The mean DAP and 3rd quartile reduced from 147 to 137 Gy.cm2 and from 192 
to 175 Gy.cm2. The SD and IQR remained high and quite stagnant for the six 
quarters analysed despite the optimization attempts. The slow reaction of the SD 




Larrazet et al. (114) noted the wide variation in complexity of PTCA procedures and 
evaluated the operator's and technique dependence. They found that mean DAP for 
PTCA and stenting was highly dependent on the operator and on the technique used 
by the cardiologist. Operator and technique differences in this study may be 
attributing to the large SD and IQR seen.  
The CA + LV + PTCA + 1, 2, 3 Stent procedures were not evaluated in detail like the 
above CA + PTCA + 1 Stent cases but still holds valuable information.  Investigation 
of the mean DAP results displayed in Table 4.2.1 shows that DAP readings increase 
when additional stents are placed. When more stents are used during a procedure it 
clearly resulted in higher mean exposure values to the patient. This trend was 
consistent for all the quarters shown in Table 4.2.1. The last quarter of this work, 
2013 Q4, shows the mean result for CA + LV + PTCA + 1 Stent (131 Gy.cm2), 2 
Stents (145 Gy.cm2) and 3 Stents (148 Gy.cm2).  
 
5.4 PPM & Biventricular PPM 
 
The pacemaker placement procedures included PPM and biventricular PPM. There 
were 1175 PPM and 280 Biventricular PPM cases recorded.  Table 4.2.4.1 and 
Table 4.2.5.1 show the amount, mean, standard deviation and different quartiles for 
the two pacemaker procedure distributions for all six quarters. PPM showed a 
reduction of mean DAP and a reduction in 3rd quartile DRL from 37 to 29 Gy.cm2 and 
from 41 to 36 Gy.cm2. The SD and IQR, for PPM, decreased from 67 to 34 Gy.cm2 
and from 32 to 31 Gy.cm2.  
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The PPM DRL histograms in Figure 4.2.4.1, showed again a neatly positively 
skewed distribution. The reduction in mean, DRL, SD and IQR is reinforced by the 
slight movement of the distribution graphs towards lower dose bins. This is similar to 
the trend observed for CA and CA + LV. The number of incident level doses 
recorded was very low in comparison to the other procedures analysed as only 9 out 
of the 1175 cases breached the 300 Gy.cm2 investigation level.  
The 3rd quartile reference level determined for PPM was the lowest of all the 
procedures investigated. The mean PPM DAP values for each theatre and for each 
quarter are shown in Figures 4.2.4.2-4. As discussed previously, theatre 12 is yet 
again clearly higher than the group mean level because of their poor radiographic 
technique.  
Biventricular PPM showed a reduction of mean DAP and a reduction in 3rd quartile 
DRL from 135 to 107 Gy.cm2 and from 144 to 117 Gy.cm2. The much higher doses 
mean doses recorded for biventricular PPM alludes to it being a more complex and 
variable procedure than normal PPM. As seen in Table 4.2.5.1 the SD and IQR, for 
biventricular PPM, was quite variable during the six quarters. Q3 2012 compared to 
Q4 2013 indicates that the SD and IQR decreased from 164 to 125 Gy.cm2 and from 
110 to 92 Gy.cm2.  
The biventricular PPM DRL histograms in Figure 4.2.5.1 show an untidy and skewed 
distribution. This histogram and the wide variation in the SD and IQR are similar to 
the trend observed for CA + PTCA + 1 Stent procedures. The histogram curve 
appears similar for all six quarters and graphically no lower dose shift or big changes 
are apparent. The number of incident level doses, of larger than 300 Gy.cm2, 
recorded for biventricular PPM reduced from 13 to 4, 5, 8, 4 and 2 during the six 
quarters starting at Q3 2012 up to Q4 2013.  
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The variation in SD and IQR, as seen for the CA + PTCA + 1 Stent, may indicate the 
complexity of the procedure. The mean SD and IQR for biventricular PPM during this 
study was 155 and 122 Gy.cm2. This is an even higher variation than seen for CA + 
PTCA + 1 Stent of 105 and 112 Gy.cm2.  Considering this, it can be alleged that the 
variation in complexity of biventricular PPM was the highest.    
The variation in the mean of biventricular PPM DAP is shown graphically in figure 
4.3.1 and the mean biventricular PPM DAP values for each theatre and for each 
quarter are shown in Figures 4.2.5.2-4. Figures 4.2.5.4 (f) shows that many theatres 
performed no biventricular PPM procedures during the six quarters. This may be 
because not all practitioners attempt these complex cases routinely. The graphs 
seen in Figures 4.2.5.2-4 visually support the high SD and IQR calculated for 
biventricular PPM. 
 
5.5 Radiofrequency Ablation 
 
The last of the six procedures included for analysis was radiofrequency ablation. 
This is an electrophysiology procedure, which should be seen as a subspecialty of 
cardiology requiring additional training. This resulted in not many hospitals 
performing ablation cases routinely. As seen in Figures 4.2.6.2-4 the most cases 
were done by theatres 2, 6, 11 and 20.  
During this study 675 radiofrequency ablation cases were recorded. Table 4.2.6.1 
show the amount, mean, standard deviation and different quartiles for the ablation 
distribution for all six quarters. RF ablation showed a reduction of mean DAP and a 
reduction in 3rd quartile DRL from 85 to 48 Gy.cm2 and from 104 to 66 Gy.cm2. The 
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SD and IQR, for RF ablation, decreased from 109 to 53 Gy.cm2 and from 88 to 57 
Gy.cm2. This is similar to the trend observed for CA, CA + LV and PPM procedures. 
The RF ablation DRL histograms in Figure 4.2.6.1, again show a neatly positively 
skewed distribution, similarly to the diagnostic procedures and PPM. The reduction 
in mean, DRL, SD and IQR is reinforced by the reduction in case frequency in the 
higher dose bins. This is similar to the trend observed for CA, CA + LV and PPM. 
The number of incident level doses recorded reduced from 8 during Q3 2012 to 4, 2, 
2, 1 and 0 for the other quarters. The mean ablation DAP values for each theatre 
and for each quarter are shown in Figures 4.2.6.2-4.  
Theatre 2 and 20 make use of a robotic catheter navigational system for 
electrophysiology and for robotic radiofrequency ablation. Lorgat et al. (125), one of 
the surgeons resident at hospital 2, explains in detail the benefits of these remote 
robotic catheter devices and specifically mentions the reduction in screening time 
and resulting radiation dose. The mean DAP value calculated for robotic 
radiofrequency ablation was considerably less than that of normal ablation without 
the robotic device. The mean DAP for robotic radiofrequency ablation was 
determined in Q4 2013 as 27 Gy.cm2. This is 56 % lower than the mean DAP for 
normal radiofrequency ablation, which is consistent with the comments made by 
Lorgat et al. (125).    
 
5.6 Other Interesting Observations 
 
EVAR procedures consistently accounted for the highest mean DAP values during 
each quarter of 2013. The mean doses for EVARs recorded for the four quarters in 
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the last year of this study was 704, 849, 375 and 515 Gy.cm2. These are 
considerably high mean doses when compared to the incident level of 300 Gy.cm2. 
Many of these cases exceeded the incident investigation level, which was of a major 
concern.  
The high mean dose of EVAR procedures is consistent with the fact that these are 
cumbersome procedures that involve a lot of screening, and was further 
investigated. In the private hospital group three of the participating theatres 
contributed > 90% of the EVAR cases. These three theatres were numbered 12, 18 
and 25. Theatre 12 recorded mean doses of: 480, 445, 764 and 579 Gy.cm2 
respectively for the four quarters of 2013. Theatre 18 recorded mean doses of: 979, 
1024, 309 and 666 Gy.cm2 respectively for the four quarters of 2013. Theatre 25 
recorded mean doses of: 480, 445, 764 and 579 Gy.cm2 respectively for the four 
quarters of 2013. These results pointed to theatre number 18 having the highest 
mean EVAR doses. Additionally they also did the most EVAR procedures and 
account for > 50% of the total EVAR cases. 
Following the first EVAR results in Q1 2013, closer investigation of the practise and 
radiological technique used in theatre 18 showed high usage of high pulse rate 
fluorography and high dose fluoroscopy during EVAR cases.  The EVAR cases in 
theatre 18 were exclusively performed by the vascular surgeons’ resident at the 
hospital. They mentioned, in consultation with the responsible medical physicists, 
that they perform highly complex cases and have become a referral centre for 
complex vascular work. Initial communication with these doctors was difficult and 
hospital administrators had to become involved to ensure all parties participated in 
optimization attempts.  
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During the last months of Q2 2013 the fluorography technique factors on the x-ray 
machine were adjusted and the lowest frame-rate that doctors would accept was 7.5 
fps for EVAR cases. Additionally to the EVAR fluorography adjustment, the default 
fluoroscopy setting on the unit was set to low dose. The IAEA optimization posters 
(101) were distributed and radiation protection training was given to radiographers, 
vascular surgeons and staff. 
Incident management added value to the optimization attempt, because most of the 
EVAR cases resulted in incidents. Part of the investigation into the high EVAR dose 
phenomenon involved consultation with other medical physicist teams (126) 
experienced in radiology. They (126) noted that these doses are likely elevated 
compared to their local levels and offered valuable advice to aid in optimization.  
It was found that, for the sake of incident investigation that the level of 300 Gy.cm2 
is, in all likelihood, too low for typical EVAR cases because the field size is typically 
much larger than 100 cm2. The responsible medical physicist attempted to reproduce 
work done by Delle et al. (127) and measure the field size using Gafchromic film, but 
it was largely unsuccessful because of the amount of movements during EVAR 
procedures, not allowing accurate field visualization.  
The likelihood of field sizes exceeding 100 cm2 for EVAR was based on the 
collimator field size and magnification settings during procedures. This means that 
the peak skin dose is lower than for procedures with smaller field sizes, and an 
investigation level of 500 Gy.cm2 may be more applicable for EVAR cases. This level 
is recommended by the IAEA SAFRAD (103) incident management system.  
Following this Q2 2013 investigation into the EVAR procedure’s radiographic 
technique, the mean doses for theatre 18 reduced to 309 Gy.cm2 for 5 cases 
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performed during 2013 Q3. This reduction in mean dose may be attributed to 
technique changes and active medical physics and hospital administrator 
involvement with the vascular surgeons performing EVAR cases. 
Other vascular procedures supporting the above argument are the 272 peripheral 
angiograms and 450 peripheral interventions performed during 2013. The mean 
doses for peripheral angiograms recorded for the four quarters of 2013 was 83, 75, 
64 and 52 Gy.cm2 respectively. Mean doses for peripheral interventions during the 
same period were 704, 849, 375 and 515 Gy.cm2 respectively. Theatre number 18 
accounted for 16 % of the peripheral angiograms and for 35 % of the peripheral 
interventions performed in all theatres. During the course of 2013, doses used for 
peripheral interventions in theatre 18 reduced from 224 Gy.cm2 (Q1 2013) to 135 
Gy.cm2 (Q2 2013), 93 Gy.cm2 (Q3 2013) and 81 Gy.cm2 (Q4 2013). The peripheral 
angiography procedures followed the same trend and doses reduced from 84 
Gy.cm2 (Q1 2013) to 107 Gy.cm2 (Q2 2013), 36 Gy.cm2 (Q3 2013) and 28 Gy.cm2 
(Q4 2013) respectively. 
 
5.7 Hypothesis Review 
 
The first part of the null hypothesis questioned if South African interventional 
cardiology radiation doses are high in comparison with international levels. Table 
4.4.1.1 shows the reference levels determined in this study when compared to 
available international levels.   
The mean international level for CA was calculated as 56.2 Gy.cm2 with a standard 
deviation of 17.6 Gy.cm2. This resulted in the deciding limit for CA of 73.8 Gy.cm2 
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which is higher that the CA DRL proposed in this work of 57 Gy.cm2. This means 
that South African private healthcare CA interventional levels are not high in 
comparison with international levels. Applying this same argument to the work done 
by Miller et al. (64) in the United States would mean their CA DRL of 83 Gy.cm2 is 
high in comparison to international levels. They conclude in this work that there is 
room for improvement in the United States and that their doses are not optimized. 
The work done in Switzerland by Aroua et al. (97) proposed a CA DRL of 80 Gy.cm2 
which may also be considered high in comparison. 
A similar result was obtained for CA + LV, CA + PTCA + 1 Stent, PPM and RF 
ablation where the South African private healthcare levels determined in this work 
was lower than the international mean. The mean international DRL for these 
procedures in order of mention was 55.5, 147.6, 28.3 and 91 Gy.cm2. The SD was 
20.5, 45.5, 14.9 and 47.1 Gy.cm2. The international mean with one SD added was 
76, 193, 43 and 138 Gy.cm2 which was less that the DRL proposed in this work of 
63, 176, 36 and 66 Gy.cm2. 
Miller et al. proposed 199 Gy.cm2 as a United States DRL for PTCA; this is high in 
comparison with the international mean calculated of 147.6 Gy.cm2. This is 
consistent with the results of CA which also indicated that doses in the United States 
are elevated.  
As with CA, the DRLs proposed by Aroua et al. (97) in Switzerland for PTCA and 
radiofrequency ablation of 260 and 140 Gy.cm2 are high in comparison to 
international mean levels plus one SD of 193 and 138 Gy.cm2. 
The evaluation of PPM showed that all the international levels fall within this range. 
Makosa & Conradie (81) proposed initial levels for a public hospital in South Africa of 
108 
 
43 Gy.cm2. This proposed level is equal to the international mean plus one SD 
calculated and shown in Table 4.4.1.1 of this work.  
 
The biventricular PPM posed a problem as only one international DRL could be 
found which made a SD calculation impossible. The biventricular PPM level of 48 
Gy.cm2 published in Greece by Perisinakis et al.  (115) was presented as a mean 
value on a study population of 14 patients. This makes a biventricular PPM 
comparison with international means not feasible for this work and no comparison 
result is proposed. 
Table 5.1 compares the proposed DRLs in this work with other 3rd quartile DRLs 
published in other countries. Where 3rd quartile results were not available in these 
publications, e.g., for biventricular PPM, the mean DAP value was used. The 
proposed DRLs compare well with the listed published data. 
 
Table 5.1: Proposed reference levels for the private healthcare sector in South 
Africa; includes baseline DRLs, amount of optimization and comparison to 
publications from other countries. The amount of procedures evaluated for each 
review period (n) is indicated below the displayed DRL value. 
 





%  International Publications (Gy.cm2) 
CA 
66 
(n = 676) 
57 
(n = 522) 
↓13 
49 (Aus – Lin et al. 2013) (112) 
83 (USA – Miller et al. 2012) (64) 
32 (Croatia – Brnic et al. 2010) (117) 
42 (Ireland – D’Helft et al. 2009) (116) 
71 (Belgium – Bogaert et al. 2008) (119) 
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45 (EU –  Padovani et al. 2008) (128) 
80 (Swiss – Aroua et al. 2007) (97) 
40 (Belgium – Dragusin et al. 2005)(48) 
57 (Europe – Neofotistou et al. 2003) (30) 
63 (Sweden – Fransson et al. 2000) (121) 
CA+ LV 
77 
(n = 1548) 
63 
(n = 818) 
↓18 
41 (Italy – Kocinaj et al. 2006) (113) 








154 (France – Larrazet et al. 2014) (114) 
199 (USA – Miller et al. 2012) (64) 
138 (Multinational – 2007) (118) 
80 (Belgium – Dragusin et al. 2005)(48) 
107(Ireland – D’Helft et al. 2009) (116) 
260 (Swiss – Aroua et al. 2007) (97) 





(n = 116) 
↓13 
43 (SA – Makosa & Conradie 2015) (81) 
21 (Ireland -  D’Helft  et al. 2009) (116) 
11 (Greece – Perisinakis et al. 2005) (115) 




(n = 84) 
117  
(n = 26) 




(n = 183) 
66 
(n = 56) 
↓45 
35 (EU – Padovani et al. 2008) (63) 
140 (Swiss – Aroua et al. 2007) (97) 
110 (Japan – Chida et al. 2006) (62) 
47 (Belgium – Dragusin et al. 2005)(48) 
123 (Ireland – McFadden et al. 2002) (120) 
 
 
The baseline DAP reading for CA established in 2012 was 65.9 Gycm2 and a total of 
676 procedures were used for the initial establishment of the DRL. This value has 
reduced to 57.1 Gy.cm2 in 2013 and 522 cases were used in its establishment.  The 
baseline for CA+LV was 76.8 Gy.cm2 calculated using 1548 procedures which 
improved to 63.3 Gy.cm2 calculated using 818 procedures. CA + PTCA, PPM, 
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biventricular PPM and radiofrequency ablation cases followed a similar trend and 
improved from 192, 41, 144 and 104 Gy.cm2 determined from 496, 284, 84 and183 
cases to 176, 36, 117 and 66 Gy.cm2 for 185, 116 ,26 and 56 procedures.  
These reductions in DRL translate to a 13% improvement for CA, 18% for CA+LV, 
9% for CA + PTCA + 1 Stent, 13% for PPM, 19 % for biventricular PPM and 45% for 
radiofrequency ablation. 
The second part of the null hypothesis focussed on whether dose optimization was 
improved or not and if the reductions in DRL noted above had statistical significance. 
The proposed t-test evaluation to prove or disprove the null hypothesis required the 
data to be normally distributed. Most DAP histograms showed, as expected, a 
positively skewed distribution. In an attempt to comply with the normal distribution 
requirements of the t-test the logarithm (base 10) of the DAP values were calculated 
and reviewed for normality using a normal probability graph.  
The normal probability graphs are shown for all six procedures in Figures 4.4.2.1-2. 
These graphs were fitted using linear equations which resulted in a coefficient of 
determination value (R2) of 0.97, 0.96, 0.99, 0.97, 0.96 and 0.98 for the six 
procedures. This is a good fit of the normal probability graphs and means that the 
Log10 of the DAP values can be considered a natural distribution which makes the t-
test an appropriate statistical tool to evaluate the null hypothesis of optimization. 
The t-test used to evaluate the null hypothesis produces three factors of importance, 
namely the t-statistic, t-critical statistic and a probability value (P). These are shown 
in Table 4.4.2.1. Theoretically the t-statistics in the t-test measures the size of the 
difference in the mean values of the distributions relative to the variation in the 
sample. If the t-statistic is larger than the t-critical statistic the null hypothesis is 
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rejected. The t-statistic goes hand in hand with the probability value and if P is less 
than 0.05 (α) it is also good reason to reject the null hypothesis.  
The CA and CA + LV t-test results shows that the t-statistic is much larger than the t-
critical statistic, 3.56 compared to 1.96. For both these procedures a very low P 
value of 0.0004 was obtained, which strengthens the large t-statistic result that 
confidently rejects the null hypothesis. This means that for CA and CA + LV it can be 
confidently said that the dose was optimized during this project. 
The CA + PTCA + 1 Stent, PPM and Ablation t-test results show a t-statistic that is 
larger than t-critical, but the difference is not as clear as in the case of CA and CA + 
LV. For these three procedures the t-statistic was 2, 2.08 and 2.33 and the t-critical 
statistic was 1.97, 1.97 and 1.98 respectively. The P values for these procedures 
were 0.047, 0.039 and 0.022 which is in agreement with the t-statistic in rejecting the 
null hypothesis. This means that for CA + PTCA + 1 Stent, PPM and radiofrequency 
ablation it can be confidently said that the dose was optimized during this project. 
However, for biventricular PPM the t-test results show a t-statistic of 0.89 which is 
smaller than the t-critical statistic of 2.02. The P value for biventricular PPM was 
calculated as 0.38 which is higher than α. This means that the t-test cannot 
confidently reject the null hypothesis for biventricular PPM.  Despite the 19% DRL 
improvement noted for this procedure, the statistics of the results do not support this. 
The high SD in the biventricular PPM cases and the low amount of procedures 
performed during Q4 2013 may have influenced the t-test results. The average SD 
for biventricular PPM was 155 Gy.cm2 with only 26 procedures recorded in Q4 2013.  
The optimization of radiation dose and improvement in DRLs may be attributed to 
various factors. This program, to the involved theatres, managed to increase their 
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awareness and understanding of the DAP measurement and the dose delivered to a 
patient. For many of these theatres this was their first involvement in DRL calculation 
or dose optimization. Baseline values, theatre averages and group averages allowed 
theatres to compare their improvement with neighbouring hospitals that often housed 
similar x-ray equipment.  
The availability of a local DRL metric, indicating a dose level that should not routinely 
be exceeded, helped the responsible medical physicists to identify, investigate and 
optimize imaging techniques. The newsletters that were sent out explicitly mentioned 
the hospitals’ names, which resulted in a degree of competition between hospitals.  
The DRL data helped the responsible physicist to engage with theaters that had the 
same equipment, but higher doses, to determine where optimization could happen. 
The improvements made to the incident management system included the definition, 
quantification or grading and guided management of incidents. This enforced the 
same radiation protection principles and helped to achieve responsible radiation 
usage.  
During the SAAPMB conference of 2007, Gray said, “typically if the radiologist in 
fluoroscopy doesn’t like the way an image looks, he tells the service engineer to fix 
this. What does the service engineer do if the radiologist doesn’t like the image? He 
turns up the exposure rate.”  (77) 
My experience during this work may include in the above statement that cardiologists 
and vascular surgeons are not much different. Unfortunately, they have much less 
knowledge and comprehension of their actions when adjusting radiographic 
techniques. The scenario discussed at theatres 12 and 18 demonstrated this. When 
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DRLs are correctly applied and form part of the dose management in interventional 
fluoroscopy, scenarios like the above can be more easily observed and addressed. 
This DRL system made outlier identification possible and theatres continually 
exceeding the DRL could be investigated and a lack of improvement could be 
questioned. The availability of a locally derived DRL and comparisons with 
achievements of other centers aided administrators to motivate, where needed, for 
the upgrading of equipment. During the course of this work some imaging 
equipment, like theater 22, was replaced or upgraded with newer technology, which 
surely had a positive impact on the DRL. 
During SAAPMB 2007 Dr Joel Gray from the United States, when closing the 
preliminary session, challenged the South African medical physicists by saying, “First 
and foremost, we have to look at optimized image quality and dose. Again my 
challenge to you, let’s look at the 50% DRL as the goal for our own departments.”  
(77) 
This concept of using the 50% DRL level for comparisons and optimization worked 
very well in the private hospital group where this study was performed. Dose levels 
were optimized and DRLs were not high in comparison to international levels. We 
can confidently say, in response to the challenge set by Dr Gray, that for CA and 
PTCA, the South African private sector DRLs appear to be even lower than those 






CHAPTER 6 CONCLUSION 
 
The NCRP report 160 (46) mentions that radiation is widely used in medicine for 
diagnostic, interventional and for functional imaging as well as for radiotherapy. The 
situation regarding X-ray imaging in South Africa is no different, as these techniques 
offer great benefit to patients. Today, many doctors from various disciplines are 
relying on digital X-ray imaging to perform surgeries and clinical procedures on 
patients. Unfortunately, use of digital X-ray technologies carries risk and can lead to 
overexposure of patients if applied incorrectly.(1) 
Ionizing radiation has the potential to cause stochastic and deterministic adverse 
radiation effects like radiation induced cancer and erythema, dermal atrophy and 
even tissue necrosis. (2, 7) Interventional theatres, and specifically interventional 
cardiology theatres, have a high usage of interventional X-ray machines.  
Unfortunately, the training of these specialist doctors does not include adequate 
radiographic technique training or radiation safety training.  Interventional procedures 
are becoming increasingly more complex in many specialities, as the types and uses 
of catheters become more advanced.(5, 16)   
In South Africa, since 2007, it has been regulated that DAP meters must be installed 
in fixed fluoroscopy units. In 2015, these regulations were updated and now require 
that patient DAP readings are optimized by a medical physicist. Currently there are 
very limited publications in South Africa, referring to DRLs and no full publications 
addressing interventional cardiology. These factors, as listed above, emphasized the 
urgent need for this work.  
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This study covered 20415 interventional procedures segregated into 24 procedure 
categories performed at 27 interventional theatres during the period of June 2012 to 
December 2013 across South Africa. Six procedures with high incidence and 
relevance were further evaluated. These represented 15473 cases, or 76% of the 
total procedure amount. 
The distribution of DAP values for complex interventions, e.g., CA+ PTCA + 1 Stent 
and biventricular PPM, displayed a high variation in the data as shown by the large 
standard deviation and inter-quartile ranges. The diagnostic procedures and less 
complex interventions, like CA, CA+LV, PPM and radiofrequency ablation, showed 
smaller deviations and inter-quartile ranges.  
EVAR procedures consistently accounted for the highest mean DAP values during 
this work. Closer investigation of the practise and the radiological technique used 
showed excessive usage of high pulse rate fluorography and high dose fluoroscopy.  
The vascular surgeons could allow technique and fluorography frame rate 
adjustment down to 7.5 fps and low dose fluoroscopy. Mean EVAR doses for 
theatres were greatly reduced by applying these simple technique changes. 
Theatre number 12 consistently, and with a large margin, exceeded the group mean 
value for many procedure types. Closer investigation into the radiographic technique 
showed that the cardiologists only use fluorography to perform their cases because 
the fluoroscopy image quality was deemed insufficient. The radiographers were 
unsuccessful in their efforts in having this poor technique changed. The medical 
physicist gave firm instructions detailing that fluorography should not be used 
routinely for screening purposes, but only when essential and when image recording 
is required. The correction of this poor technique and some additional optimization 
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training resulted in theatre 12’s mean CA dose reducing by 44% and CA +LV by 
34%. 
The research question introduced in this work has two parts. Firstly, “Are radiation 
doses used in South African private healthcare interventional laboratories high 
compared to those published internationally” and secondly, “will establishing dose 
reference levels optimize the doses used?” 
The mean and SD of DRLs from many countries worldwide was calculated. 
Comparisons with the DRLs from this work and these international mean values plus 
one SD were made. To address the first part of the null hypothesis, it can confidently 
be concluded that South African private healthcare doses are not high in comparison 
with international levels. 
The second part of the null hypothesis was whether DRLs would optimize radiation 
doses used. The t-test results showed that it can confidently be concluded that for all 
procedures, except for Biventricular PPM, DRLs optimized doses within the six 
quarters of this review. The uncertainty highlighted by the t-test done on Biventricular 
PPM was likely caused by the wide variation in the doses and the low case numbers 
recorded for the last quarter. 
These reductions in DRLs, that the t-tests have confirmed to be statistically 
significant in all but one study, translate to a 13 % improvement for CA, 18 % for 
CA+LV, 9 % for CA + PTCA + 1 Stent, 13 % for PPM, 19 % for biventricular PPM 
and 45 % for Radiofrequency Ablation. 
One challenge for small centres and also for uncommon procedures, like 
Biventricular PPM, is to get enough cases in a dataset to provide a statistically useful 
117 
 
result. This is especially difficult when there is a wide SD and IQR in a distribution. 
Calculating a DRL for procedures with a low frequency remains challenging.  
Considering the importance of DRLs, I feel the expression “miners’ canary” may 
have relevance to theatres with low numbers or poor statistics for complex 
interventions. The metaphor originates from the times before technology when there 
were no real-time gas meters in coal or other mines. These miners of old used to 
carry caged canaries while at work. The theory behind this was, if there were 
dangerous levels of methane or carbon monoxide in the mine, the canary would die. 
This “miners’ canary” would be an early warning system. The expression “miners’ 
canary” or “canary in a coal mine” has been used widely as a metaphor to indicate 
possible triggers or identifiers before obvious symptoms appear. (129-131) The 
evaluation of local DRLs of diagnostic procedures and simple interventions, which 
have higher case numbers and neater distributions, may be the “miners’ canary”. 
Should the simpler diagnostic procedures indicate elevated DAP levels compared to 
the DRL, then this may indicate bigger problems for interventions, because the same 
dose optimization and reduction principles apply for diagnostic procedures and 
complex cases. 
The reductions seen were not without challenges and it remains difficult to engage 
the specialist doctors who control the dose. Attempts to provide free training and 
advice were largely unsuccessful because specialists working in their private 
capacity do not have time or possibly interest to attend such sessions. The lack of 
training of these doctors is a big problem and the examples of theatres 12 and 18 
detailed in this work are testament to it.  
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A possible solution to this could be compulsory training programmes that insist that 
all specialists using X-rays should have radiation protection training when 
specializing.  This would mean approaching all academic hospitals or even the 
Health Professions Council of South Africa, to make it part of the curriculum. 
Limited comparisons between private and public sector doses have recently become 
possible because of the abstract published by Makosa & Conradie (81) from one 
South African public healthcare institution in 2015. They published initial levels of 
153 Gy.cm2 for CA and 43 Gy.cm2 for PPM. These levels appear high compared to 
the private sector doses proposed in this work of 57 Gy.cm2 and 36 Gy.cm2. 
However, this is a very small sample and no real conclusion can be made by this 
comparison. 
For the majority of the 27 interventional theatres that participated, this was their first 
attempt at dose optimization and for many their first interaction with a medical 
physicist. The realization of dose management and the training of professionals that 
work in these theaters resulted in an awareness shift. Radiation dose quantifies, like 
the DAP reading, that were previously unnoticed in some theatres, have become an 
important dimension to assess high quality interventional techniques.   
We attribute the improvement seen to various factors, including increased 
awareness created, changes in imaging techniques, new and upgraded imaging 
equipment and the improvement of incident management. This is an on-going study 
within the private hospital group where this work was done. Following this initial 




It is generally accepted that the benefit of interventional radiology, compared to the 
risks of complicated invasive surgery, greatly outweighs the deterministic and 
stochastic radiation risks inherent in the modality.  We must, without question, avoid 
any deterministic effects of radiation and also restrict stochastic risks, and DRLs can 
highlight problem areas.  
This research aimed to establish if DRLs in the South African private healthcare 
interventional theatres are high compared to international levels and whether DRLs 
will optimize the doses used. The results indicate that South African doses are not 
high in comparison and that establishing an on-going DRL program to monitor and 
compare radiation doses used in intervention, will assist with dose optimization 
leading to lower patient radiation doses.  
I propose, based on the number of cases recorded and the national spread of the 
participating private hospital group in South Africa, that these DRLs could be 
considered guidance to interventionists in the private sector, attempting to optimize 
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CHAPTER 8 ANNEXURE 
8.1 Ethical Considerations  
The information used in this dissertation already exists and was retrospectively 
analysed as an audit. The recording of the information used is a legislated 
requirement from the Department of Health, Directorate Radiation Control. (DoH 
DRC). The latest equipment licensing requirements entail that the user records and 
optimizes DAP readings for patients in fixed fluoroscopy procedures. (17) The 
proposed data was anonymised at the source and no patient names or numbers 
exist in the data set.  
The data includes the hospital name, procedure name, date of screening and the 
DAP reading of procedures done in a private hospital group's facilities from June 
2012 until December 2013.  All hospital names were removed from the dataset. Any 
incidents/problems noticed in the data that could potentially be harmful to the patient 
were recorded by the hospital concerned on their Incident Management System 
(IMS) and handled separately according to the applicable internal policies and 
legislation pertaining to such incidents. 
The University of Cape Town, Human Research Ethics Committee, granted approval 
for this study under the reference HREC REF: 254/2014. Additionally, the private 
healthcare institution, Research Operations committee, granted ethical approval for 





8.2 Procedure Descriptions 
 
Table 8.2.1: Procedure name and descriptions used for the first 14 procedures 
included in the study. Procedure descriptions were mostly sourced from web based 
sources used for patient educational purposes. 




Angiogram) /                     
Cardiac 
Catheterization       
Cardiac Catheterization/Coronary Angiography is an invasive 
test to find out whether or not there are any narrowing or 
blockages in the coronary arteries and how well the heart is 
pumping.   A vessel in the right leg is punctured with a needle 
and then a small plastic tube, called a catheter is passed up to 
the heart arteries under x-ray guidance. A special x-ray dye is 
then injected which allows pictures of the heart to be seen and 
information is recorded permanently.(132) 
Cerebral 
Angiography 
Cerebral Angiogram Cerebral angiography is a test that enables doctors to see a 
map of the blood vessels in the brain and the neck by using a 
contrast agent (special dye) and fluoroscopy.  It also helps to 
show how blood flows between the different parts of the 
circulation.  Typically a catheter is inserted into a large artery 
(such as the femoral artery) and threaded through the 
circulatory system to the carotid artery, where a contrast agent 
is injected. A series of radiographs is taken as the contrast 
agent spreads through the brain's arterial system, then a second 
series as it reaches the venous system. (133) 
Renal 
Angiography 
Renal Angiogram /                      
Renal Arteriography  
This is a study of the blood vessels of the kidneys.  It is done by 













Angioplasty (PTCA) /                                        
Percutaneous 
Coronary 
Angioplasty (PCA)  
 Angioplasty is the technique of widening blocked / narrow 
cardiac arteries with a balloon.  This is a way of opening up 
blocked / narrowed coronary arteries and increasing the blood 
flow to the area of heart muscle they supply. The initial part of 
the procedure is the same as for coronary angiography, except 
the catheter has a balloon tip. Once the catheter is in place a 
thin wire, called a guide wire, it is threaded through the catheter 
towards the narrowed section of the artery. Over this the doctor 
will advance the angioplasty catheter that has a balloon at the 





CA + Coronary 
Angioplasty (+Stent) 
/                                                   
PTCA & Stent/                                      
Stent 
A stent is a small, metal coil that helps keep a “ballooned” artery 
open. It acts as a support on the inside of the artery.                                
Stents are mounted on a balloon catheter. The process for 
implanting a stent is the same as a coronary angioplasty except 
when the balloon is inflated, the stent is imbedded to the inside 
of the artery, while the balloon is deflated and removed. Thus 
leaving the stent behind. Include procedures where multiple 
stents are used. 
Ablation (RF) Catheter Ablation - 
Radio Frequency /                                
Cardiac RF ablation /                                          
Radio Frequency 
ablation 
Catheter ablation is an invasive procedure used to remove a 
faulty electrical pathway from the hearts of those who are prone 
to developing cardiac arrhythmias.  Catheter ablation uses a 
series of thin, flexible wires (catheters) that are inserted through 
an artery or a vein (usually in the groin or neck) and guided to 
the heart.  The catheter tip is an electrode which then delivers a 
low-voltage, high-frequency current that destroys the heart 
tissue responsible for the arrhythmia.  This procedure will also 
include some electrophysiological studies. 
137 
 
Ablation (RF + 
Robotic) 
All Catheter ablation 
using a Robotic 
device                                                              
Pulmonary Ablation - 
RF + Robotic               
Pulmonary vein ablation is a treatment for atrial fibrillation.  It is 
standard catheter ablation done on one or more of the four 
pulmonary veins using a robotic device.  There are very few 
hospitals that do this procedure.  
EPS Electro Physiology 
Study 
An electrophysiology study (EPS) is a minimally invasive 
procedure which tests the electrical conduction system of the 
heart to assess the electrical activity and conduction pathways 
of the heart.  The study is to investigate the cause, location of 
origin, and best treatment for various abnormal heart rhythms. 
CA + LV 
function 
CA + LV function                                
Left Ventriculography 
Left Cardiac Ventriculography is a medical imaging test used to 
determine a patient's cardiac function in the left ventricle. 
Cardiac ventriculography involves injecting contrast media into 
the heart's ventricle to measure the volume of blood pumped.  
The 3 major measurements obtained by cardiac 
ventriculography are: Ejection Fraction, Stroke Volume & 
Cardiac Output.  This procedure will also include a Coronary 
Angiogram, but Right Ventriculography (RV) should not be 
included in this study.(134) 
CA + LV + 
Angioplasty  
(Balloon) 
 This is a Cardiac Left Ventriculography study with an 
Angioplasty.  During this procedure the patient's cardiac function 
will be evaluated where after the blocked arteries will be opened 
with a catheter with a balloon tip.   
CA + LV + 
Angioplasty  (+ 
Stent) 
 This study is identical to a LV function study with an 
Angioplasty, but this includes a Stent placing. Includes 
procedures where multiple stents are used. 
Pacemaker 
(Permanent) 
Pacemaker/                                                   
PPM 
A pacemaker (or artificial pacemaker, so as not to be confused 
with the heart's natural pacemaker) is a medical device that 
uses electrical impulses, delivered by electrodes contacting the 










A biventricular pacemaker is a type of pacemaker that can pace 
both the septal and lateral walls of the left ventricle. By pacing 
both sides of the left ventricle, the pacemaker can resynchronize 
a heart whose opposing walls do not contract in synchrony, 
which occurs in approximately 25-50 % of heart failure 
patients.(135) 
TAVI Valve placement /                   
Trans catheter Aortic 
Valve Implantation  
A catheter with a balloon tip is inserted through the groin into the 
heart.   Once the end of the balloon is in the aortic valve, the 
balloon is inflated to stretch open the narrowed aortic valve. This 
is called valvuloplasty.  A new valve is then carefully 
compressed and mounted onto another balloon delivery 
catheter, using a specially designed device, and threaded into 
the aortic valve.  The balloon is used to expand the new valve. 
The new valve is designed to settle itself in place firmly. 
 
Table 8.2.2: Procedure name and descriptions used for the additional 10 procedures 
included in the study in January 2013. Procedure descriptions were mostly sourced 
from web based sources used for patient educational purposes. 






This is a Cerebral/Neuro-Angiogram followed by any 




Angiogram /  
Peripheral 
Arteriogram 
A peripheral angiogram is a test that uses X-rays to help your 
doctor find narrowed or blocked areas in one or more of the 
arteries that supply blood to your legs. 
Peripheral 
Interventions 
  During peripheral interventions doctors open blocked or 








This is an Electro Physiology study preceded with a coronary 
angiogram. 
CA + EPS + 
Ablation 
CA + EPS + 
Catheter ablations 
This is an Electro Physiology study preceded with a coronary 
angiogram and follow by a cardiac ablation.  Cardiac ablation is 
a procedure that is used to destroy small areas in your heart that 
may be causing your heart rhythm problems. 
CA + LV + 
Angioplasty +  
2 Stent 
CA+ LV + 
Angioplasty (+ 
Stent)         LV + 
Stent 
This study is identical to a LV function study with an Angioplasty, 
but this includes a Stent placing. 
CA + LV + 
Angioplasty +  
3 Stent 
CA+ LV + 
Angioplasty (+ 
Stent)         LV + 
Stent 
This study is identical to a LV function study with an Angioplasty, 





Endovascular aneurysm repair (EVAR) is an alternative to open 
surgery for the treatment of abdominal aortic aneurysms (AAAs). 
Permcaths Central Venous 
Catheters 
(Permanent)                           
Permanent 
Catheters 
This is when a catheter is permanently (or for a long term) 





Diagnostic left & 
right heart 
This study only includes paediatric cases (all other cases are 
excluded).   During cardiac catheterization, doctors thread long, 
flexible tubes, called catheters, up through a child's large blood 
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catheters vessels and into the heart. These catheters allow them to 
measure pressures and draw blood samples. They use these 
measurements to determine how blood is flowing to different 
parts of your child's body. Sometimes an angiogram is included 







8.3 Dose Optimization Newsletters 
 
 











8.4 Optimization Program Advances 
 
This dissertation details the aim, important decisions, and results of the first six 
quarters of the DRL and dose optimization project done in a South African private 
hospital group.  
This first year and a half of implementation was a learning experience for everyone 
involved, which includes the medical physicists. The teething lessons and problems 
that were mentioned included (lack of) doctor participation, procedure descriptions 
determination and some system problems. Considering the legislation in South 
Africa (17), the longevity of a project like this required the development of an online 
system to assist with data collection and also improve accuracy.  
The online system was developed by the private medical physics division in 
conjunction with programmers employed by the private hospital institution. This 
program was tested by a few beta hospitals in September 2013, after which it went 
live in January 2014. Since then the system is running with minimal supervision. 
Theatres are able to access their data and don’t need to wait for quarterly feedback 
letters to assess their improvement or lack thereof. Figures 8.4.1-2 shows 
screenshots of the online system on the intranet of the private hospital group. Figure 
8.4.3 shows screenshots of messages displayed by the online system if high doses 
are entered.  
During the SAAPMB congress of 2015 further reference level advice and possible 
DRLs were presented. (136) This updated work originated from the lessons learnt in 




Figure 8.4.1: A screenshot of the online dose optimization system.  
 
Figure 8.3.2: The data input page of the online dose optimization system. 
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Figure 8.3.3: Screenshots of the pop-up warning messages produced by the online 
system should a high value be entered. 
